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During neurodevelopment, processes like neurogenesis, neuronalmigration andmor-
phogenesis, as well as synaptogenesis determine the shape and function of the brain. All
developmental events are highly coordinated by extrinsic and intrinsic signaling path-
ways. e ubiquitin-proteasome system emerges as specific intrinsic regulator of brain
development as well as target for therapeutic approaches. In this study, I identified
the UPS component and an F-box protein FBXO41 as a CNS-specific protein expressed
exclusively in neurons. I found that FBXO41 specifically stimulates axon growth in
cerebellar granule neurons in vitro and in vivo. In addition, I discovered that FBXO41 is
crucial for the migration of CGNs in the developing cerebellar cortex. At the molecu-
lar level, I also found that FBXO41’s centrosomal localization is important for its role in
neuronal migration but not for axon growth. In addition, I uncovered that FBXO41 asso-
ciates with DISC1 to cooperate in neuronal migration but this interaction is dispensable
for axon growth regulation. Taken together, my study led to the identification of the
novel CNS-specific F-box protein FBXO41 and the characterization of its role in crucial
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1.1. Mechanisms of neuronal migration and
morphogenesis
e mammalian brain is one of the most complex organs. Its development involves
a sequence of highly orchestrated events, including neurogenesis, migration, neuronal
morphogenesis and migration as well as synapse formation to integrate neurons into a
fully functional network.
Neuronal morphogenesis andmigration are tightly controlled by a variety of extrinsic
and intrinsic mechanisms. e extracellular regulators of neural development include
growth factors, extracellular matrix proteins and cell adhesion molecules (Dijkhuizen
and Ghosh, 2005, Huber et al., 2003, Katz and Shatz, 1996, Markus et al., 2002a, Tessier-
Lavigne and Goodman, 1996). ese factors bind extracellular receptors and trigger
diverse signaling pathways. Morphological analyses of dissociated neurons in culture
demonstrated however, that neurodevelopmental processes are also governed by cell-
intrinsic mechanisms. In particular transcription factors and the ubiquitin-proteasome
system were shown to play a critical role in neural development (Konishi et al., 2004,
Stegmüller et al., 2006, Jan and Jan, 2003, Arloa et al., 2005, Arnaud et al., 2003a, Feng
et al., 2007, Kim et al., 2005, Wang et al., 2003, Gaudillière et al., 2004). Ultimately
the extrinsic and intrinsic pathways converge and act on the cytoskeleton (Barnes and
Polleux, 2009, Chhabra and Higgs, 2007, Dehmelt and Halpain, 2004).
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1. Introduction
1.1.1. Neuronal migration in the telencephalon and cerebellum
Newly born neurons migrate considerable distances to reach their destination where
they form synaptic connections. ree major types of migration can be distinguished
in the developing telencephalon: radial, tangential and chain migration.
During radial migration in the developing cortex, newly generated excitatory neu-
rons migrate outwards from the subventricular zone to the pial surface. Here, later-
born neurons migrate past the ones that have already seled. As a consequence, the
older neurons reside in the deeper cortical layers, while the younger neurons form the
superficial layers. As these neurons migrate, they move along radial glial fibers, that
extend from the subventricular zone to the pial surface. Because of this fact, radial
migration is considered to be a gliophilic migration (Figure 1.1, Rakic (1978)).
Figure 1.1.: Routes of neuronal migration in the developing telencephalon and the
cerebellum. Inhibitory interneuron progenitors originate from medial ganglionic em-
inence (MGE) and migrate tangentially towards the cortical plate (blue arrow). Exci-
tatory projection neurons are generated from progenitors residing in the subventricu-
lar zone and migrate radially towards the pial surface in a glia-guided manner (black
arrows). Progenitors of the cerebellar granule neurons migrate tangentially from the
upper rhombic lip to the external granule layer (EGL) where they generate neurons
(green arrow). ese in turn, migrate radially to reach the internal granule layer. Mod-
ified from Haen (2002).
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In contrast to radial migration, which applies mostly to excitatory neurons, GABAer-
gic interneurons that originate from the lateral and medial ganglionic eminences mi-
grate tangentially to reach the cortex. Another difference between the tangential and
radial migration is the developmental stage of the neurons. While neuronal progenitors
migrate tangentially, newly born neurons undertake radial migration. Additionally,
during tangential migration neurons do not rely on glial support but oen associate
with other neurons, hence it is referred to as neuronophilic migration (Figure 1.1, An-
derson et al. (1997), Tamamaki et al. (1997), Wichterle et al. (1999), Métin et al. (2008)).
Inhibitory interneurons undergo yet another type of migration, termed chain migra-
tion. It occurs from the subventricular zone to the olfactory bulb in the rostral migra-
tory stream and provides new GABAergic interneurons throughout life (Luskin, 1993,
Alvarez-Buylla, 1997). While migrating towards the olfactory bulb, these neurons form
a chain surrounded by tubular structures that consist of glial cells (Figure 1.1, Wichterle
et al. (1997)).
Apart from the cerebral cortex and olfactory bulb, neuronal migration also occurs
in the hippocampus and cerebellar cortex. In the laer, cerebellar granule neurons
(CGNs) migration continues way into the postnatal period (Altman, 1972). During de-
velopment CGNs migrate both tangentially and radially. CGN progenitors originating
from the upper rhombic lip (also: germinal trigone) within rhombomere 1 (Altman,
1972, Wingate and Haen, 1999), first undertake dorsorostral migration to reach the
external granule layer (EGL, Figure 1.1). ere, newly generated postmitotic neurons
migrate tangentially until they change their migratory direction and continue to move
radially along Bergmann glia, eventually arriving in the internal granule layer (IGL). In
contrast to projection neurons in the cerebral cortex, CGNs are generated adjacent to
the pial surface and migrate inwards as they mature (Figure 1.2, Altman (1972), Ryder
and Cepko (1994), Wingate and Haen (1999), Métin et al. (2008)).
Neuronal movement during migration consists of repeating cycles, each involving
two events. First, the leading process dynamically extends and retracts, which results in
the net elongation of the process. In the second step, which occurs aer a certain delay,
the soma enters the leading process, followed by a retraction of the trailing process
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Figure 1.2.: Radial migration of newly born CGNs in the developing cerebellum. Pro-
genitors residing in the external granule layer (EGL) generate cerebellar granule neu-
rons (CGNs) that first accumulate in the premigratory zone (PMZ). Later, the CGNs
migrate along Bergmann glia (BG) towards the internal granule layer (IGL), passing the
molecular layer (ML) and the Purkinje cell layer (PCL). By the time the migration is
completed, the EGL is depleted. PC - Purkinje cell. Modified from Heng et al. (2012).
(Edmondson and Haen, 1987, Komuro and Rakic, 1995).
Proper neuronal migration results from a coordinated action of extracellular fac-
tors, such as guidance cues, growth factors, morphogenic proteins and cell adhesion
molecules, acting through intracellular regulatory pathways, which include transcrip-
tion factors and the ubiquitin-proteasome system that ultimately act on the cytoskele-
ton.
1.1.2. Extracellular cues in neuronal migration
Neuregulins, Netrins, Semaphorins and Slits constitute major families of guidance
cues involved in neuronal migration. Here, Neuregulin 1 (NRG1) binds to the ErbB4
receptor to act as a chemoaractant for tangentially migrating interneurons (Yau et al.,
2003). NRG1 is expressed in two isoforms, type III and type I/II NRG1, which differ
both in their spatial distribution and their function in guiding interneurons towards the
4
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cortex. NRG1 type III is membrane bound and serves as a permissive substrate along
the route of interneuron migration. NRG1 type I/II undergoes proteolytic cleavage and
thus forms a concentration gradient directing the interneurons towards the developing
pallium (Flames et al., 2004).
Apart from serving as aractive cues, these guidance proteins also function as che-
morepellents. For instance, interneurons are prevented from entering the striatum by
the repulsive action of Semaphorin (Sema) 3A and 3F, which bind to the Neuropilin re-
ceptors 1 and 2, respectively (Marıń et al., 2001, Nóbrega-Pereira et al., 2008). Netrin1
in turn, acts via its receptor DDC (deleted in colorectal cancer) to exert a dual role in
neuronal migration. While Netrin1 serves as a chemoaractant for pontine neurons mi-
grating from the rhombic lip, it repels the cerebellar neurons from the EGL and the
striatal neurons from the subventricular zone (Alcantara et al., 2000, Marin and Ruben-
stein, 2001).
Furthermore, growth factors, in particular BDNF (brain-derived neurotrophic factor),
NT4 (Neurotrophin-4) and GDNF (glial cell line-derived neurotrophic factor) promote
migration of cortical and cerebellar neurons (Polleux et al., 2002, Pozas and Ibáñez,
2005). Intracellular mechanisms involved in this regulation may include PI3K/AKT and
ERK pathways (Polleux et al., 2002, Segarra et al., 2006). Ca2+-dependent autophospho-
rylation of TrkB receptor has been shown to be implicated in BDNF and NT-4 signaling
(Behar, 1997).
Importance of the extracellular matrix components in neuronal migration was de-
monstrated by the reeler mutant mouse, which exhibits lamination defects accompa-
nied by ataxia, tremor and reeling gait. Reelin, the protein mutated in this mouse, is
an extracellular glycoprotein, which binds to VLDLR (Very-low-density-lipoprotein re-
ceptor) and ApoER2 (Low-density lipoprotein receptor-related protein 8). e reelin
signaling requires tyrosine phosphorylation of Dab1 (Disabled-1) by nonreceptor pro-
tein kinases Src and Fyn (Arnaud et al., 2003b, Bock and Herz, 2003).
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1.1.3. Cytoskeleton in migrating neurons
In radially migrating neurons, microtubules exhibit a well-structured yet dynamic
configuration. ey form a cage-like structure surrounding the nucleus (perinuclear
cage, Rivas et al. (1995)), associated with the centrosome which precedes the nucleus
towards the migratory direction (Vallee et al., 2009) and provides a link to the micro-
tubules invading the leading process (Tanaka et al., 2004, Tsai et al., 2007).
A broad array of microtubule associated proteins (MAPs) regulate tubulin dynam-
ics. MAPs stabilize and destabilize microtubules. In addition, posranslational modi-
fications of both MAPs and tubulin regulate the affinity of one another (Gelfand and
Bershadsky, 1991). MAP1b and Tau are structural MAPs and have been shown to reg-
ulate neuronal migration, as knockout of MAP1b or Tau in mice causes disruption of
hippocampal layering and a decrease in motility of isolated cerebellar neurons (Takei
et al., 2000).
Other microtubule binding proteins, like lissencephaly 1 (LIS1) and Doublecortin
(DCX) have been found to be vital for proper development of the mammalian brain.
Mutations in the LIS1 gene have been linked to lissencephaly (smooth brain) in humans,
a condition characterized by a smooth cerebral surface, aberrant neuronal migration,
severe mental retardation as well as seizures, ultimately resulting in death during early
childhood (Reiner et al., 1993, Ross et al., 1997). Doublecortin (DCX) also controlsmigra-
tion of cortical neurons (Bai et al., 2003) and mutations in the DCX gene are associated
with X-linked lissencephaly as well as double cortex syndrome (Gleeson et al., 1998).
Both LIS1 and DCX bind to microtubules to increase their stability and promote cen-
trosome coupling to the nucleus during neuronal migration (Tsai et al., 2007, Moores
et al., 2004, Solecki et al., 2009).
During neuronal migration, certain proteins and organelles have to be transported
from and to the distal parts of the neurons. e intracellular transport is carried out
by molecular motors. Cytoplasmic dynein, a minus end-directed microtubule motor
protein, has been shown to be essential for the centrosomal and nuclear translocation
but not for the extension of the leading process of migrating neurons (Tsai et al., 2007).
MAPs constitute important regulators of molecular motors. Dynein activity is mod-
6
1.1. Mechanisms of neuronal migration and morphogenesis
ulated by proteins like LIS1, NDE1 and NDEL1 (Vallee et al., 2009). LIS1 activates cy-
toplasmic dynein, which is localized at the leading process and exerts a pulling force
on microtubules and the centrosome (Tsai et al., 2007). In contrast to the centroso-
mal translocation, nuclear movement might also be mediated by a LIS1 and dynein
that localize to the nuclear envelope and associate with microtubules in the perinuclear
cage (Tsai et al., 2007). Among others, RanBP2 (RAN binding protein 2), SUN1 and 2
(Sad1 and UNC84 domain containing 1 and 2), Syne-1 and 2 (spectrin repeat contain-
ing, nuclear envelope 1) have been suggested to mediate the connection of dynein to
the nuclear envelope (Splinter et al., 2010, Zhang et al., 2009b).
Besides themicrotubules, the integrity of the actin cytoskeleton is crucial for neuronal
migration, considering that suppression of actin polymerization results in inhibition of
neuronal movement (Rivas et al., 1995). Consistent with this finding, disruption of actin
function underlies several neurodevelopmental disorders associated with defective mi-
gration, such as bilateral periventricular nodular heterotopia (Fox et al., 1998, de Wit
et al., 2009), classic lissencephaly (Kholmanskikh et al., 2003, 2006) or lissencephaly with
cerebellar hypoplasia (D’Arcangelo et al., 1995, Schmid et al., 2005).
Major regulators of the actin cytoskeleton are Rho GTPases, which are either in an
active, GTP-bound or inactive, GDP-bound state. Active Rho GTPases are able to bind
effector proteins and modulate the cytoskeleton. ree members of the Rho GTPase
family RhoA, Rac1 and Cdc42 have been extensively characterized in neuronal devel-
opment (Govek et al., 2011). Processes like interkinetic nuclear migration, cycling of
cortical neurons progenitors and soma translocation during radial migration in the
cortex require actin depolymerization (Chai et al., 2009), which is regulated by actin-
disassembling proteins like cofilin and Rho GTPases.
1.1.3.1. The Centrosome during neuronal development
e centrosome or microtubule organizing center (MTOC), is believed to be the main
site of microtubule nucleation in the cell (Baas et al., 2005a, Higginbotham and Glee-
son, 2007). Various proteins involved in neuronal migration, like DISC1, NDEL1, LIS1 or
DCX localize to the centrosome (Morris et al., 2003, Sasaki et al., 2000, Feng et al., 2000,
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Tanaka et al., 2004), establishing the MTOC as an essential cellular structure in migrat-
ing neurons. During migration, movement of the centrosome into the leading process
precedes the translocation of the nucleus (Solecki et al., 2004, Tanaka et al., 2004, Vallee
et al., 2009). is observation prompted the hypothesis that the centrosome transfers
the pulling force of the microtubules in the leading process to the perinuclear cage, en-
abling the movement of the nucleus. Evidence by Solecki and colleagues revealed that
overexpression of PAR6α (part of the PAR3-PAR6-aPKC polarity complex) in neurons
causes disruption of the perinuclear cage as well as inhibition of centrosomal movement
and neuronal migration (Solecki et al., 2004). On the other hand, migrational analysis
in cerebellar slices uncovered that the nuclear translocation along the microtubules
can also occur independently of the centrosomal position relative to the nucleus. is
finding suggests an additional, acentrosomal force acting on the nucleus in migrating
neurons (Umeshima et al., 2007).
1.1.4. DISC1 - a converging point of the signaling pathways in
neuronal migration
Disrupted in Schizophrenia 1 (DISC1) is considered to be a risk gene for schizophre-
nia and related psychiatric disorders (Millar et al., 2000b, Ekelund et al., 2001, Hennah
et al., 2003). Since its identification, several studies have described the role of DISC1
in various neurodevelopmental processes, including the regulation of neural progeni-
tor proliferation, neurite outgrowth and neuronal migration (Mao et al., 2009, Kamiya
et al., 2006, 2005). Since no enzymatic activity has been ascribed to DISC1 until now,
it is believed to exert its function by interacting with a plethora of proteins, many of
which are cytoskeletal regulators.
1.1.4.1. DISC1 as a susceptibility gene for schizophrenia
DISC1 was discovered during a study a Scoish family suffering from mental dis-
orders. In this family, a balanced translocation between chromosomes 1 and 11 was
found to co-segregate with schizophrenia, major depression and bipolar disorder (St
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Clair et al., 1990, Millar et al., 2000a, 2001). e aforementioned translocation disrupts
the DISC1 gene and an antisense non-coding RNA, DISC2 gene (Millar et al., 2000a).
Meanwhile, various linkage and association studies confirmed the relationship between
the DISC locus and several psychiatric disorders (Ekelund et al., 2000, Hwu et al., 2003,
Ekelund et al., 2004). On the other hand, many studies showed no correlation (Sanders
et al., 2008, Houlihan et al., 2009, Okuda et al., 2010) however the examined SNPs also
varied between the studies, so the link of variations in the DISC1 gene to major mental
disorders remains under debate.
1.1.4.2. Localization of DISC1
Human DISC1 transcript has been detected in various neural and non-neural tissues,
with the highest expression in placenta, heart and brain (Millar et al., 2000b). In rodents,
the most abundant expression is detectable in the heart, with weaker expression in the
brain, kidney, liver and testis (Ma et al., 2002, Ozeki et al., 2003).
Within the human brain, DISC1 is highly expressed in the dentate gyrus (Lipska et al.,
2006, James et al., 2004), but lower expression has been also detected in the temporal
and parahippocampal cortex (Lipska et al., 2006). High levels of mouse DISC1 mRNA
and protein are found in the dentate gyrus, while lower levels have been reported in
cerebellum, cerebral cortex, ammon’s horn, olfactory bulbs, paraventricular and arcuate
nuclei of the hypothalamus and amygdala (Ma et al., 2002, Miyoshi et al., 2003). Promi-
nent expression in the dentate gyrus supports the possibility that DISC1 constitutes a
genetic risk factor for schizophrenia, since the hippocampus has been associated with
the pathology of this disease (Csernansky et al., 2002, Lawrie et al., 1999, Friston et al.,
1992, Venables, 1992, Kerwin et al., 1988).
In humans, DISC1 is upregulated during prenatal and neonatal period, as well as dur-
ing puberty (Lipska et al., 2006). Expression of mouse DISC1 peaks at E13.5 when the
neurons are generated and at P35, when the animals enter puberty (Schurov et al., 2004).
is expression profile indicates that DISC1 may play an important role in neurodevel-




At the subcellular level, DISC1 localizes to mitochondria (Ozeki et al., 2003, James
et al., 2004), the centrosome (Kamiya et al., 2005, 2006) and the cytoplasm, where it
colocalizes with cytoskeletal components like F-actin (Miyoshi et al., 2003), α-Tubulin
(Brandon et al., 2004, 2005), MAP2 (Brandon et al., 2005) and gelsolin (James et al.,
2004). In cultured primary neurons and neuronal cell lines, DISC1 expression has been
detected in the cell body, nucleus, neurites and growth cones (Ozeki et al., 2003, James
et al., 2004, Ogawa et al., 2005, Brandon et al., 2005, Shinoda et al., 2007, Taya et al.,
2007). Interestingly, the subcellular localization of DISC1 undergoes changes during
cell differentiation. In rodent PC12 cells and SH-SY5Y, a human neuroblastoma cell
line, DISC1 translocates from the cytoplasm to the processes as the cells differentiate
(Ozeki et al., 2003, James et al., 2004).
Immunohistochemistry of human cortical slices demonstrated that DISC1 localizes to
the cell bodies and apical dendrites of pyramidal neurons and glial cells. Furthermore,
DISC1was detected in axon terminals, postsynaptic density, dendritic spines, ribosomes
and dendritic shas (Sawa and Roberts, 2006).
1.1.4.3. Genomic and protein structure of DISC1
Four alternative transcripts of human DISC1 have been detected until now. e Long
splice form (L) consists of 13 exons, the Long variant (Lv) form results from skipping 66
distal nucleotides of exon 11, the Short (S) form utilizes a 3’UTR of intron 9, producing
an alternative exon 9a, and the Extremely short (Es) form skips the splicing donor site
of exon 3 and includes 2 codons from intron 3 before using an alternative STOP codon.
In mouse, two splice variants are known so far: the first one contains at least exons 1-8
and the second one corresponds to the human Es form (Taylor et al., 2003).
Although no crystal structure of DISC1 is available, the human full length protein
has been predicted to contain an N-terminal “head” domain, encompassing amino acids
1-350, corresponding to exons 1-2 and a C-terminal “tail” domain, consisting of amino
acids 351-854, which corresponds to exons 3-13 (Millar et al., 2000b, 2001). e N-
terminal fragment accommodates a predicted nuclear localization signal and a short
alpha-helix motif (Bord et al., 2006, Ma et al., 2002, Taylor et al., 2003). e C-terminal
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fragment in turn is far more conserved and contains several predicted coiled-coil do-
mains, mediating protein-protein interactions (Taylor et al., 2003).
1.1.4.4. DISC1 in regulation of neuronal migration
DISC1 is involved in the control of early stages neuronal migration, and acts as a
molecular switch between neuronal proliferation and the initiation of migration. Two
mechanisms involved in this regulation have been identified so far. On the one hand,
the interaction of DISC1 with nonphosphorylated Dixdc1 (DIX domain containing 1)
favors neural progenitor proliferation via the WNT/GSK3β signaling. On the other
hand, the phosphorylation of Dixdc1 by Cdk5 (cyclin-dependent kinase 5) promotes
DISC1 binding to NDEL1. Dixdc1 interaction with DISC1 and NDEL1 has been shown
to be indispensable for neuronal migration, as the knockdown of Dixdc1 or disrup-
tion of DISC1-Dixdc1 binding leads to disturbed migration in cortical neurons (Singh
et al., 2010). Phosphorylation of DISC1 at S710 constitutes another mechanism that
triggers the transition from proliferation to migration. Non-phosphorylated DISC1
preferentially binds GSK3β and thus regulates neural progenitor proliferation. S710-
phosphorylated DISC1 in turn, interacts with BBS1 and BBS4 to promote migration
(Ishizuka et al., 2011a).
e role of DISC1 in the control of neuronal migration differs depending on the de-
velopmental stage and the brain region. While DISC1 RNAi inhibits migration of the
cortical neurons (Kamiya et al., 2005) and of the granule neurons in the deveploping
hippocampus (Meyer and Morris, 2009), it does not influence migration of pyramidal
neurons in the developing CA1 hippocampal region (Meyer and Morris, 2009). How-
ever another group observed that migration of CA1 pyramidal neurons at later stages
was disturbed by DISC1 downregulation (Tomita et al., 2011). In contrast, DISC1 knock-
down in the adult hippocampus causes excessive migration of the dentate gyrus neu-
rons (Duan et al., 2007). Regulation of migration in the adult dentate gyrus seems to be
mediated by the Akt pathway and the actin-binding protein Girdin (Kim et al., 2009).
Additionally, DISC1 has been implicated in the regulation of adult dentate gyrus neuron




A major site of DISC1 activity to regulate neuronal migration is the centrosome.
DISC1 is required for the centrosomal localization of CAMDI (coiled-coil protein as-
sociated with myosin II and DISC1), which regulates proper positioning of the centro-
some during neuronal migration (Fukuda et al., 2010). Additionally, DISC1 has been
found to interact with APP (Amyloid Precursor Protein) and this interaction is neces-
sary for DISC1 centrosomal localization (Young-Pearse et al., 2010). Furthermore, APP
and DISC1 seem to cooperate in the regulation of neuronal migration, since migra-
tion defects caused by the knockdown of APP can be rescued by DISC1 overexpression
(Young-Pearse et al., 2007, 2010). Moreover, interaction of DISC1 and BBS4 (Bardet-
Biedl syndrome 4) is essential for recruiting PCM1 (pericentriolar material 1) to the
centrosome and thus for the regulation of neuronal migration (Kamiya et al., 2008).
Furthermore, the genetic variants of DISC1 S740C and L607F disturb the centrosomal
localization of PCM1 (Eastwood et al., 2010, 2009).
DISC1 has been also implicated in regulation of microtubule structure and func-
tion. A microtubule spin down assay using SH-SY5Y cells demonstrated that DISC1
is found in the microtubule fraction and binds to microtubule associated proteins, like
MIPT3 (Microtubule-Interacting Protein Associated With TRAF3) or MAP1A (Morris
et al., 2003). Along this line, overexpression of DISC1 leads to a disrupted microtubule
network and to the accumulation of polymerized microtubules at the cell periphery
(Kamiya et al., 2005). DISC1 also associates with the microtubule motor proteins: the
plus end-directed kinesin-1 and the minus end-directed dynein (Kamiya et al., 2005,
Shinoda et al., 2007). Sincemotor proteins are involved in the transport of cellular cargo,
it is not surprising that DISC1 is required for the transport of e.g. Grb2 (growth factor
receptor-bound protein 2) and Girdin along the axons to the growth cones (Enomoto
et al., 2009, Shinoda et al., 2007, Taya et al., 2007). Girdin is essential for neuronal mi-
gration and morphogenesis, since its overexpression in the adult dentate gyrus leads
to excessive migration of the newly born neurons, which become mispositioned in the
outer granule cell layer and molecular layer (Kim et al., 2009). Furthermore, the Girdin
knockout mouse exhibits defects in the mossy fiber pathfinding and misplaced neurons
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in the dentate gyrus (Enomoto et al., 2009).
1.1.5. Interaction of NDEL1 and DISC1 in developing brain
NDEL1 (nuclear distribution element-like 1) is an important regulator of neural devel-
opment and one of the best characterized binding partners of DISC1. Processes like cy-
toskeletal organization, intracellular transport, membrane trafficking, enzymatic reac-
tions (harboring oligopeptidase activity), and cell signaling (by interacting with Cdc42)
have been aributed to NDEL1 function (Nguyen et al., 2004, Shu et al., 2004, Liang
et al., 2004, 2007, Hayashi et al., 2005, Guo et al., 2006, Kamiya et al., 2006, Mori et al.,
2007, 2009, Shen et al., 2008, Shim et al., 2008, Toth et al., 2008, Yamada et al., 2008,
Ma et al., 2009, Zhang et al., 2009a). Additionally, several studies implicated NDEL1 in
neuronal migration (Sasaki et al., 2005) and demonstrated that the interaction of DISC1
and NDEL1 is required in this event. Consistently with this finding, migration defects
caused by the knockdown of DISC1 are further enhanced by knockdown of NDEL1
RNAi, suggesting a functional interaction of both proteins (Duan et al., 2007).
e DISC1-NDEL1 complex controls neuronal migration mainly by interacting with
cytoskeletal regulators. One of the mechanisms of NDEL1 action involves binding to
dynein and LIS1 (Torisawa et al., 2011). NDEL1 acts to activate dynein motility by
directly interacting with the molecular motor, resulting in its dissociation from the mi-
crotubules (Torisawa et al., 2011). Additionally, LIS1 acts as an inhibitor when bound to
dynein and its interaction with NDEL1 releases this inhibition, which also contributes
to dynein activation (Torisawa et al., 2011, Żyłkiewicz et al., 2011).
During migration, NDEL1 binds to LIS1 and dynein on the nuclear envelope and the
subsequent activation of the molecular motor causes retrograde nuclear transport to-
wards the centrosome in the migratory direction. Consistent with that, NDEL1 knock-
down increases the distance between the nucleus and the centrosome, which results in
the neurons stalled in the ventricular and subventricular zones (Shu et al., 2004).
Not only microtubules but also the actin cytoskeleton is regulated by NDEL1, e.g. by
regulating the activity of small GTPases. NDEL1 sequesters Cdc42 GAP (Cdc41 GTPase-
activating protein) that inactivates Cdc42. is results in the accumulation of active
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Cdc42 at the leading edge, which in turn is essential for proper neuronal migration
(Shen et al., 2008).
Additionally, NDEL1 harbors endo-oligopeptidase activity, and processes neuropep-
tides including neurotensin (Camargo et al., 1983, Hayashi et al., 2005). Interessingly,
the interaction with DISC1 inhibits the enzymatic activity of NDEL1, which may lead
to altered levels of neuropeptides in the brain (Hayashi et al., 2005).
1.1.6. Axon specification and extension
Axon specification in vivo is closely related to neuronal migration. During radial mi-
gration, cortical and hippocampal pyramidal neurons form two kind of processes. A
leading process, which precedes the cell body responding to guidance cues and even-
tually gives rise to dendrites, and a trailing process that forms the axon (Rakic, 1971,
1972, Shoukimas and Hinds, 1978).
Newly born CGNs migrating tangentially along the molecular layer, also form a lead-
ing and a trailing process on either side of the cell body, however both processes will
eventually become an axon. As CGNs initiate radial migration towards the IGL, a third
process is formed, perpendicular to the first two and becomes the new leading pro-
cess. e two processes created initially during tangential migration, fuse to generate
a T-shaped axon, anchored in the ML and connected to the migrating cell body. Fasci-
culated axons in the ML form so called parallel fibers (Altman and Bayer, 1997, Ramon
y Cajal, 1995, Kawaji et al., 2004).
In vitro axon specification has been extensively studied in dissociated neuronal cul-
tures. Cultured neurons transition through well-defined stages, from an unpolarized
cell to a neuron with distinct axonal and dendritic domains (Fig. 1.3, Doi et al. (1988)).
e tip of a growing axon is equipped with a highly specialized structure, the growth
cone, which constantly explores the environment, senses extracellular cues and re-
sponds to them with a directional movement (Bentley and O’Connor, 1994, Tanaka
and Sabry, 1995, Suter and Forscher, 2000, Song and Poo, 2001). Growth cones con-
sist of two main domains, the peripheral domain (P-domain) and the central domain
(C-domain), distinct in their shape and their molecular composition. e P-domain
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Figure 1.3.: Stages of cortical neuron polarization in vitro. Stage 1: dissociated cor-
tical neurons form filopodia and lamellipodia-like protrusions. Stage 2: several indis-
tinguishable neurites are formed. Stage 3: one of the processes starts rapid outgrowth
and acquires axonal characteristics. Stage 4: axon and dendrites elongate and branch
rapidly. Stage 5: mature neuron with dendritic spines and functional synapses. Modi-
fied from Barnes and Polleux (2009).
contains dynamic, finger-shaped filopodia protruding from flaened edges of lamel-
lipodia. Filopodia and lamellipodia are rich in actin and invaded by single dynamic
microtubules (Bridgman and Dailey, 1989, Letourneau, 1983). e C-domain in turn, is
less dynamic but characterized by intensive microtubule polymerization and organelle
transport (Dent and Gertler, 2003).
Axon elongation can be divided into three steps: protrusion, engorgement and con-
solidation. First, filopodia and lamellipodia are generated, which is driven mainly by
polymerization of actin. In the second step, vesicles and organelles are transported to
the growth cone. Finally, during the consolidation step, the proximal part of the growth
cone is forming an extension of the axon and organelle transport becomes bidirectional
(Goldberg and Burmeister, 1986).
1.1.7. Regulation of neuronal morphogenesis
During neuronal morphogenesis, extracellular cues and intracellular signaling path-
ways ensure proper axon pathfinding and wiring of the brain. Extracellular signals in-
clude neurotrophins, for instance NGF (nerve growth factor), BDNF (brain-derived neu-
rotrophic factor), NT-3 (neurotrophin-3), and NT-4/5 (neurotrophin-4/5Bibel and Barde
15
1. Introduction
(2000)). Additionally, molecules like semaphorins (Pasterkamp and Kolodkin, 2003),
netrins (Kennedy, 2000), Slits (Brose and Tessier-Lavigne, 2000) and ephrins (Kullander
and Klein, 2002), as well as sonic hedgehog (Shh) (Charron et al., 2003), bone morpho-
genetic proteins (BMPs) (Butler and Dodd, 2003), and Wingless-type (Wnt) (Lyuksyu-
tova et al., 2003) proteins serve as guidance cues for growing axons.
Extracellular cues together with their neuronal receptors act to mediate aractive and
repulsive responses. us, regulation of receptor expression provides a mechanism to
control axon growth and guidance. Another level of control is ensured by intracellular
pathways relaying extracellular signals to the cytoskeleton. Most of these pathways
involve Rho GTPases, but recently DISC1 emerged as a promising candidate to integrate
cytoskeletal rearrangements and extracellular signaling.
Cytoskeletal dynamics directly drive morphological changes in developing neurons.
During initial neurite outgrowth, local microtubule stabilization has been shown to
specify which one of the yet unpolarized processes will become the axon (Wie et al.,
2008). Furthermore, Tanaka and colleagues demonstrated that the dynamic behavior
of microtubules is indispensable for axon elongation (Tanaka et al., 1995). While axon
pathfinding depends mainly on the actin cytoskeleton, there is growing evidence that
microtubules are involved in this process as well. Microtubule orientation in the growth
cone has been shown to be an indicator of the future axon outgrowth direction (Sabry
et al., 1991, Tanaka and Kirschner, 1995). Axon turning is yet another event controlled
by microtubules, as local manipulations of microtubule dynamics using caged drugs
causes the growth cone to change the direction (Buck and Zheng, 2002).
Several studies demonstrated that structural MAPs are essential for neuronal mor-
phogenesis. For instance, MAP2 has been implicated in dendrite outgrowth, as its loss
causes reduction of dendritic length (Harada et al., 2002). Additionally, MAP1b and
Tau localize to the growth cone and regulate neuronal migration as well as neurite out-
growth (Takei et al., 2000, 1997, Gonzalez-Billault et al., 2002, DiTella et al., 1996).
e phosphorylation status ofMAPs greatlymodifies theirmicrotubule-binding prop-
erties and is essential for regulating neuronal morphogenesis and migration. For in-
stance, MAP1b and Tau, phosphorylated by GSK3β (glycogen synthase kinase 3 β),
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change the stability of the microtubules and influence neuronal polarization (Gonzalez-
Billault et al., 2004, Sperbera et al., 1995). Spatial regulation of GSK3β activity (low in
axons, high in dendrites) ensures precise control of neuronal polarization (Jiang et al.,
2005, Oinuma et al., 2007). Another MAP regulated by GSK3β is APC (adenomatous
polyposis coli), a protein localized to the tip of a growing axon. Its phosphorylation by
GSK3β results in loss of APC binding to microtubules. As a consequence, the destabi-
lized microtubules cause growth cone pausing (Purro et al., 2008). Moreover, GSK3β-
mediated phosphorylation of CRMP-2 (collapsin-response mediator protein 2), abun-
dantly present at axon tips, prevents it from stabilizing microtubules. Neurotrophin-3
inhibits GSK3β, which in turn causes CRMP-2 dephosphorylation resulting in axon
growth stimulation (Yoshimura et al., 2005).
Additionally, actin cytoskeleton regulation by Rho GTPases plays an important role
in neuronal morphogenesis. Cdc42 in its GTP-bound state is known to bind and ac-
tivate N-WASP (neuronal Wisko-Aldrich syndrome protein). e activated N-WASP
can then promote filopodia formation via Arp2/3 (actin-related protein 2/3), which has
actin-polymerizing activity. In contrast, Rac1 is involved in lamellipodia formation by
binding to WAVE1, which also stimulates Arp2/3 activity (Goley and Welch, 2006, Pak
et al., 2008). Stimulation of filopodia and lamellipodia formation by Cdc42 and Rac1, re-
spectively, promotes neurite extension (Nobes and Hall, 1995, Ridley et al., 1992). Addi-
tionally, RhoA binds to its effector mDia, which in turn interacts with profilin to induce
localized actin polymerization and focal adhesion formation (Watanabe et al., 1997).
Interaction with mDia mediates the axon growth-promoting effect of RhoA (Arakawa
et al., 2003). However, RhoA also acts to inhibit axon growth, utilizing a pathway that
includes binding to its other effector ROCK (Govek et al., 2005).
1.1.8. DISC1 in neuronal morphogenesis
DISC1 function in neuronal morphogenesis is mainly related to the centrosome, the
growth cone and the axon, where it facilitates the transport of cellular cargo. Centro-
somal DISC1 interacts among others with pericentrin (PCNT), which is necessary for
its function in regulating microtubule nucleation and aster formation (Shimizu et al.,
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2008). Pericentrin is essential for proper neural development, since mutations in this
gene are associated with a form of dwarfism exhibiting reduced brain size (Griffith et al.,
2008, Rauch et al., 2008). Centrosomal PCM1 plays an important role in recruitment of
pericentrin to the centrosome, which is a prerequisite for proper microtubule organiza-
tion (Dammermann and Merdes, 2002). DISC1 together with BBS4 recruit PCM1 to the
centrosome (Kamiya et al., 2008), which in turn is essential for axonal morphogenesis
(de Anda et al., 2010) and embryonic neurogenesis (Ge et al., 2010).
Furthermore, interaction with FEZ1 (fasciculation and elongation protein zeta-1), is
believed to mediate the neurite growth-promoting effect of DISC1 overexpression in
PC12 cells. is hypothesis is consistent with the increased binding of DISC1 and FEZ1
during neuritogenesis in these cells. It is also bolstered by the finding that overexpres-
sion of the FEZ1-binding domain of DISC1 has a dominant negative effect on neurite
extension. Modulation of the cytoskeleton at the growth cone may be a possible mech-
anism of neurite outgrowth regulation by both proteins (Miyoshi et al., 2003).
Another interacting partner of DISC1 implicated in neurite outgrowth is DBZ (DISC1-
Binding Zinc–finger protein). Haori and colleagues found that, similar to FEZ1, over-
expression of DISC1-interacting region of DBZ inhibits neurite elongation in PC12 cells
and in hippocampal neurons (Haori et al., 2007).
In growing axons, DISC1 cooperates with kinesin to transport various cargo proteins
to the growth cones. For instance Grb2 has been shown to be transported by DISC1-
kinesin complex and its accumulation at the growth cone depends on the interaction
with DISC1. Additionally, DISC1 and Grb2 binding is required for neurotrophin (NT-3)-
mediated axon extension (Shinoda et al., 2007). Another cargo transported by kinesin
in a DISC1-dependent manner in the LIS1-NDEL1-14-3-3ε complex. Axon elongation
depends on DISC1-mediated anterograde transport of the NDEL1/LIS1/14-3-3ε complex
by kinesin-1, since knockdown of DISC1 abrogates this transport and inhibits axon
growth (Taya et al., 2007). Moreover, overexpression of a DISC1 mutant, which fails to
bind to NDEL1 causes defects in neurite outgrowth in PC12 cells (Kamiya et al., 2006).
Selective stabilization of microtubules, which is required for axonogenesis is also con-
nected to NDEL1 translocation to the axon hillock, resulting from its phosphorylation
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at serine 251 by Aurora-A kinase (Mori et al., 2007).
LIS1 and NDEL1 also form a complex with NDE1 (nuclear distribution protein nudE
homolog 1). DISC1 has been shown to connect the LIS1/NDEL1/NDE1 complex to the
activity of PDE4 (Phosphodiesterase 4), which controls the local levels of cAMP. It has
been demonstrated that NDE1 is phosphorylated at T131 by PKA (protein kinase A) to
modulate its interaction with LIS1 and NDEL1. PKA is activated by cAMP and phospho-
rylates NDE1 in a DISC1-PDE4 dependent manner. Overexpression of NDE1 mutant
that mimics the T131 phosphorylation, inhibits neurite outgrowth in rat myeloma NS-1
cells indicating that DISC1 modulates the NDE1 function in neuronal morphogenesis
(Bradshaw et al., 2011).
1.2. Ubiquitin-proteasome system in neural
development
In recent years, the ubiquitin-proteasome system (UPS) has emerged as one of the
major regulators of extracellular and intracellular signaling in developing neurons. For
instance, ubiquitin-proteasome-mediated degradation of DAB1 is essential for reelin
signaling, which regulates the actin cytoskeleton (Arnaud et al., 2003a) and defective
DAB1 ubiquitination causes excessive migration of neurons (Feng et al., 2007, Simó
et al., 2010). Furthermore, loss of netrin-1 responsiveness aer midline crossing may be
mediated by proteasomal degradation of the netrin receptor DCC (Kim et al., 2005, Hu
et al., 1997). Additionally, Cdh1-APC ubiquitinates FBXO31 in a proteolytic manner to
restrict the axon growth (M. Vadhvani, unpublished data). FBXO31 in turn, mediates
the ubiquitination of PAR6α in the control of axon growth (Vadhvani et al., 2013).
Also small GTPases are regulated by ubiquitination. SMURF1 and SMURF2 ubiquiti-
nate inactive RhoA and Rap1B respectively to regulate neuronal polarity (Wang et al.,
2003, Schwamborn et al., 2007). Additionally, active Rap2 is ubiquitinated by NEDD4,
which results in promoting the dendrite growth (Kawabe et al., 2010). SMURF1 itself is
ubiquitinated and targeted for proteasomal degradation by yet another ubiquitin ligase,
Cdh1-APC (Kannan et al., 2012b). Cdh1-APC has been also shown to act upstream of the
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p250GAP, a Rho GAP, which stimulates axon growth (Kannan et al., 2012a). Moreover,
Cdh1-APC targets the transcription factors SnoN and Id2 for proteasomal degradation
in the control of axon growth (Stegmüller et al., 2006, Lasorella et al., 2006).
1.2.1. Protein ubiquitination as a posranslational modification
Ubiquitination is a modification that, analogous to phosphorylation or acylation, is
used by almost all eukaryotic cells to regulate protein function. ree enzymes are re-
quired to aach ubiquitin, a highly conserved 76-amino acid polypeptide, to the target
protein. First, the E1 ubiquitin activating enzyme catalyzes binding of an ATP molecule
to the C-terminal glycine of ubiquitin (Ciechanover et al., 1981, Hershko et al., 1981,
Haas et al., 1982). Next, the activated ubiquitin is transferred to the E2 ubiquitin con-
jugating enzyme, by the formation of a thioester bond. Finally, the E3 ubiquitin lig-
ases mediate the covalent aachment of ubiquitin to a lysine on the substrate (Her-
shko et al. (1983), Fig. 1.4). However, ubiquitination of cysteine, serine and threonine
residues have also been reported (Cadwell and Coscoy, 2005, Ravid and Hochstrasser,
2007, Wang et al., 2007).
Traditionally, proteasomal degradation has been considered the only outcome of pro-
tein ubiquitination. However, over the recent years, our understanding of possible ubiq-
uitination functions has dramatically increased. Ubiquitination can regulate transcrip-
tion, endocytosis, protein interactions and protein activity (Hicke, 2001). For compre-
hensive list of ubiquitination functions, see Fig. 1.5.
e number of aached ubiquitin moieties and the way they are linked to each other
constitutes a code, that determines the fate of a ubiquitinated protein. A substrate
is monoubiquitinated if a single ubiquitin molecule is aached to it. Aaching sin-
gle ubiquitins at several position on one substrate is called multimonoubiquitination.
Polyubiquitination is a process of aaching a ubiquitin chain. Such chains can be ho-
motypic (homogeneous), when one specific lysine of ubiquitin is used to covalently
aach the subsequent ubiquitin, or heterotypic (heterogeneous), with ubiquitins that
are connected by various linkages in one chain. All the seven lysines (Lys6, Lys11,
Lys27, Lys29, Lys33, Lys48 and Lys63) and the N-terminal Met1 (creating linear chains)
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Figure 1.4.: Protein ubiquitination requires three different enzymes. Ubiquitin (Ub) ac-
tivated by E1 is passed to E2 and a thioester intermediate is formed. Subsequently ubiq-
uitin is transferred to the substrate that is recruited by E3. Modified from Hochstrasser
(2009).
of ubiquitin can be used to form polyubiquitin chains (Ikeda and Dikic (2008), Behrends
and Harper (2011), Komander and Rape (2012) Fig. 1.5).
1.2.2. E3 ubiquitin ligases
Among the three enzymes involved in the ubiquitination process, E3 ubiquitin lig-
ases are the most numerous (around 600 in humans, as compared to two E1s and ap-
proximately 30 E2s) and the most interesting, since they confer substrate specificity
(Scheffner et al., 1995). e family of ubiquitin ligases can be separated into two ma-
jor classes: RING (really interesting new gene)-type and HECT (homologous to E6AP
carboxyl terminus)-type E3 ubiquitin ligases. e transfer of ubiquitin to a substrate
by a HECT-type ligase requires the formation of a transient thioester bond with the E3.
In contrast, RING E3 ligases function as scaffolds to facilitate the transfer of ubiquitin
from the E2 onto the substrate (Rotin and Kumar, 2009, Deshaies and Joazeiro, 2009).
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Figure 1.5.: Functions of specific modes of ubiquitination. Ubiquitin can be aached to
the substrates as single moieties or chains of various configurations. Different types of
ubiquitination specify the fate of the protein. Modified from Wong and Cuervo (2010).
When RING ligases are involved, the E2 enzymes specify the type of ubiquitin chain
formed. In contrast, the C-terminus of HECT ligases alone determines the ubiquitin
linkage type (Kim and Huibregtse, 2009).
1.2.3. SCF complex and F-box proteins
e SCF (Skp1, Cullin 1, F-box) complex is a conserved RING-type E3 ubiquitin ligase
first identified in budding yeast (Feldman et al., 1997, Skowyra et al., 1997). It consists of
four components: Skp1 (S phase kinase-associated protein 1), Cul1 (Cullin 1), F-box pro-
tein (FBP) and a RING finger-containing Rbx1 (RING-box protein 1). F-box proteins act
as variable adapters, recognizing and recruiting different sets of substrates (Deshaies,
1999). Apart from the SCF complex, various other Cullin–RING ligases (CRLs) have
been identified, which utilize different Cullins and substrate recruiting adapters (Fig.
1.6).
All F-box proteins (FBPs) share a common, approximately 40 amino acid motif - the
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Figure 1.6.: Various Cullins with their substrate recognition adapter proteins. 8 dif-
ferent Cullins (CUL) have been identified until now and most of them have been shown
to form CRLs (Cullin-RING ligases) analogous to the SCF (Skp1, Cullin1, F-box) com-
plex, but with different components that fulfill the functions of F-box proteins and Skp1.
Cullin 7 forms an SCF-like complex, but only one F-box protein (FBXW8) is known to
interact with it so far (Sarikas et al., 2008). Modified from Skaar et al. (2013).
F-box domain, which was first identified in Cyclin F (Bai et al., 1996). FBPs have been
subdivided into three groups: FBXW, FBXL and FBXO, reflecting their domains com-
position. FBXW proteins are characterized by aWD40 domain, Leu-rich repeat domain
is present in FBXL proteins and the other FBPs have been categorized as FBXO (F-box
only) proteins. Distinct domains of FBPs play different roles within the SCF complexes.
e F-box domain is responsible for binding to Skp1 and Cul1, and the various addi-
tional domains are believed to serve as substrate-binding sites (Jin et al., 2004).
For some of the F-box proteins, a degron recognition motif has been characterized
on their substrates (Ravid and Hochstrasser, 2008). Since several proteins can carry the
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same degron, this mechanism enables FBPs to recognize multiple targets. However,
several levels of regulation ensure that the substrates are degraded in a spatially and
temporally controlled manner. First of all, the best characterized FBPs recognize only
phosphorylated degrons. For instance βTRCP recognizes a motif: Asp-pSer-Gly-Xaa-
Xaa-pSer, and FBXW7 recognizes a sequence: pr-Pro-Pro-Xaa-pSer where Xaa is any
amino acid and pSer or pr are phosphorylated serine or threonine) (Wu et al., 2003,
Welcker and Clurman, 2008). In some cases a sequential phosphorylation by several
kinases is required for target recognition, increasing the stringency of the process. For
instance, GSK3β can only phosphorylate JUN when it is already phosphorylated by
another kinase (Wei et al., 2005) erefore, the availability and activation of specific
kinases regulates protein ubiquitination. Several other protein modifications can also
facilitate substrate recognition. For example FBXO2 binding to pre-integrin β1 and
FBXO6 binding to T cell receptorα-chain depends on the glycosylation of the substrates
(Glenn et al., 2008). Conversely, some modifications can block substrate recognition by
the FBPs. FBXL2 cannot bind phosphorylated p85β and the binding is promoted by
protein tyrosine phosphatase (PTPL1)-mediated phosphorylation (Kuchay et al., 2013).
Not all F-box proteins exert their function as part of an SCF complex, although several
of these actions still involve binding to Skp1. SCF-independent functions of F-box pro-
teins have been predominantly characterized in budding yeast, where M1 andMdm30
are involved in mitochondria fusion and tubule formation (Dürr et al., 2006). More-
over, Ctf13 interacts with Skp1 and constitutes a part of the CBF3 kinetochore binding
complex (Kitagawa et al., 1999). Some F-box proteins also harbor enzymatic activity,
including the helicase Fbh1, which unwinds DNA in an ATP-dependent manner (Kim
et al., 2002, 2004).
1.2.3.1. F-box proteins in neuronal development and disease
e human genome encodes more than 70 F-box proteins (Jin et al., 2004), however
the function of only few of them has been characterized. Most of these studies focus on
the role of F-box proteins in cell cycle and thus their implications in cancer (Skaar et al.,
2009, Frescas and Pagano, 2008, Welcker and Clurman, 2008, Frescas and Pagano, 2008).
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Growing evidence supports their involvement in development and function of the ner-
vous system. FBPs have been shown to regulate various stages of neurodevelopment,
from neural progenitor proliferation, neuronal migration and morphogenesis.
During neurogenesis, the degradation of REST (RE1-silencing transcription factor)
by SCFβ−Trcp ensures proper neural progenitors differentiation (Westbrook et al., 2008).
FBXW7 in turn, controls neural development by ubiquitination of Notch and c-JUN,
which is essential for neural progenitor differentiation and apoptosis (Hoeck et al.,
2010). Furthermore, FBXL10, which is a subunit of the PRC1 (Polycomb repressive
complex 1) E3 ligase, monoubiquitination of the histone 2A, which is essential for
proper differentiation of embryonic stem cells (Wu et al., 2013). e FBXL10-deficient
mouse shows an increase in apoptosis and neural progenitor proliferation. Additionally,
roughly half of these mice suffer from exencephaly and retinal coloboma resulting from
a failure of neural tube closure, which causes death shortly aer birth (Fukuda et al.,
2011). Downregulation of the FBP, Skp1 (FBXL1), has been demonstrated to increase
the proliferation of Xenopus neuronal precursors, while its overexpression decreases
neurogenesis. is effect is SCF-dependent and requires the degradation of the cyclin
dependent kinase inhibitor, Xic1 (Boix-Perales et al., 2007).
Neuronal morphology is also regulated by of FBPs. For instance, it has been shown
that depletion of FBXW7 disrupts axonal arborization of Purkinje cells in mouse cere-
bellum (Jandke et al., 2011). On the other hand, dendrite morphology is regulated by
FBXW8 that targets Grasp65 for proteasomal degradation and thereby regulates Golgi
morphology (Lierman et al., 2011). Apart from that, downregulation of FBXO31 has
been shown to inhibit neurite growth and to disturb establishment of axon-dendrite
polarity (Vadhvani et al., 2013).
Additionally, the loss of FBXO45 in mice causes defects in cerebral axonal tracts and
in the innervation of the diaphragm, as well as aberrant formation of neuromuscular
synapses. Interestingly, the innervation defects are not caused by the inability of neu-
rons to grow axon but rather a pathfinding defect, since the outgrowth of processes was
observed in the isolated FBXO45 knockout neurons (Saiga et al., 2009).
Many of the FBPs play versatile roles in neurodevelopment, regulating its several
25
1. Introduction
aspects. For instance, knockdown of FBXO31 also inhibits migration of CGNs, which
has been shown by using in vivo electroporation of postnatal rat cerebellum (Vadhvani
et al., 2013). Moreover, FBXO45 knockout mice exhibit defects in radial and tangential
migration in the telencephalon (Saiga et al., 2009). Additionally, knockout of FBXW7
in mice cerebellum causes premature CGN migration and mispositioning of Purkinje
neurons (Jandke et al., 2011).
Apart from their role in neural development, several F-box proteins have also been
implicated in pathogenesis of neuronal disorders. Mutations in FBXO7 gene have been
shown to cause a form of juvenile Parkinsonism (Fonzo et al., 2009). Moreover, it has
been demonstrated that the levels of the F-box protein FBXL2 decrease in the temporal
but not the frontal cortex of the Alzheimer’s disease (AD) patients. Interestingly, it is
the temporal cortex that undergoes degeneration in AD (Watanabe et al., 2013). Addi-
tionally, FBXO2 has been suggested to be a possible target of Alzheimer’s disease ther-
apy, since its overexpression in an ADmouse model decreased the β-amyloid levels and
ameliorated the synaptic defects. e underlying mechanism involved ubiquitination
and proteasomal degradation of BACE1 (β-site APP-cleaving enzyme 1) (Gong et al.,
2010). Moreover, FBXO2 has been shown to act with Skp1 but independently of the
SCF complex to control the inner ear function and the targeted knockout of FBXO2 in
mice causes progressive hearing loss (Nelson et al., 2007).
1.2.4. Aim of the project
F-box proteins are not only important players in the control of cell cycle but emerged
also as regulators of neurodevelopment and potential targets of therapeutic approaches
(Hirota et al., 2012, Wu et al., 2012b, Orlicky et al., 2010, Aghajan et al., 2010, Sakamoto
et al., 2001, 2003). Hence, it is important to learn more about novel F-box proteins with
a role in brain development and disease. e goal of my thesis was to characterize the
previously undescribed, CNS-specific F-box protein FBXO41 in neurodevelopment. e
first aim of the study was to elucidate the expression of FBXO41 in the developing brain
using biochemical and immunocytochemical methods. e second aim of the project
combined in vitro and in vivo approaches to investigate the role of FBXO41 in neuronal
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migration and morphogenesis, and to identify interactors of FBXO41 to establish an
FBXO41 pathway in developing neurons.
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2. Materials and methods
2.1. Chemicals and kits
Unless otherwise stated, the chemicals used in this study were purchased fromMerck
(Darmstadt, Germany), Sigma-Aldrich (Munich, Germany), Roth (Karlsruhe, Germany),
Applichem (Darmstadt, Germany), Biomol (Hamburg, Germany), Serva Electrophore-
sis (Heidelberg, Germany), Invitrogen (Darmstadt, Germany), Becton Dickinson and
Company (USA) and Worthington (UK).
NucleoBond® Xtra Midi EF, NucleoSpin® Plasmid ickPure kits and NucleoSpin®
Gel and PCR Clean-up kit were from Macherey-Nagel (Düren, Germany). ikChange
II Site-Directed Mutagenesis Kit was ordered from Agilent Technologies (USA), Human
Fetal Brain Mate & Plate® Library was from Clontech Laboratories, Inc. (USA).
2.2. Antibodies
Primary antibodies used in this study are listed in the table below. Secondary anti-
mouse IgG and anti-rabbit IgG antibodies conjugated to fluorophores (Alexa Fluor 488
or 555) or horse radish peroxidase were bought from Dianova (Hamburg, Germany).
Anti-goat IgG antibody coupled to horse radish peroxidase was from Santa Cruz Bio-
technology.
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Target Host Application Company
FBXO41 rabbit WB (1:250) Eurogentec (custom
made)
GFP rabbit WB (1:1000), ICC (1:1500) Invitrogen
GFP mouse WB (1:1000), IHC (1:100) Santa Cruz Biotechnology
myc mouse WB (1:2000), ICC (1:250) Santa Cruz Biotechnology
Flag mouse WB (1:1000), ICC (1:250) Sigma-Aldrich
β-galactosidase mouse WB (1:500) Santa Cruz Biotechnology
γ-Tubulin mouse WB (1:5000) Sigma-Aldrich
pan 14-3-3 mouse WB (1:20 000) Santa Cruz Biotechnology
PLP mouse WB (1:150) Prof. Klaus-Armin Nave,
Max Planck Institute of
Experimental Medicine,
Göingen, Germany
GFAP rabbit WB (1:500) Promega
DISC1 goat WB (1:500) Santa Cruz Biotechnology
NDEL1 rabbit WB (1:1000) Abcam
Cdc42 rabbit WB (1:250) Cell Signaling Technology
Katanin p60 rabbit WB (1:250) Sigma-Aldrich
MAP2 mouse ICC (1:1000) Sigma-Aldrich
CC3 rabbit WB (1:1000) Cell Signaling Technology
total ERK1/2 rabbit WB (1:1000) Promega
phospho-ERK1/2 rabbit WB (1:1000) Cell Signaling Technology
total Akt rabbit WB (1:1000) Cell Signaling Technology
phospho-Akt rabbit WB (1:1000) Cell Signaling Technology
SnoN rabbit WB (1:500) Santa Cruz Biotechnology
Cullin1 mouse WB (1:1000) Santa Cruz Biotechnology
Cullin7 mouse WB (1:1000) Sigma-Aldrich
NFM mouse WB (1:500) Santa Cruz Biotechnology




Experiments were carried out with the following equipment: pipees (Gilson, USA),
plastic ware (Eppendorf, Germany, Sarstedt AG, Germany and Greiner Bio-One, Ger-
many), centrifuges (Eppendor), rocker and shaker (Heidolph, Germany), thermocycler,
(Biometra, Germany), heater block (Grant Instruments, UK), spectrophotometer (GE,
UK), fluorescent microscope (Eclipse Ti), inverted light microscope (Eclipse TS100) and
dissection microscope (SMZ645) (Nikon, Japan).
2.4. Enzymes
e enzymes used in this study are listed below:
Enzyme Company
Restriction enzymes New England Biolabs
GoTaq® DNA polymerase Promega
Pfu DNA polymerase ermo Scientific
Calf intestinal phosphatase New England Biolabs
T4 DNA ligase Fermentas
T4 polynucleotide kinase NEB
T4 DNA polymerase Fermentas
2.5. Solutions
Following solutions were used through the course of the study:
PBS: 137 mM NaCl, 10 mM KCl, 20 mM Na2HPO4, 20 mM KH2PO4 pH 7.4
PBST: PBS, 0.1% Tween 20
Running buffer: 25 mM Tris base, 190 mM glycine, 0.1% SDS
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Transfer buffer: 20 mM Tris base, 153 mM glycine, 20% methanol
Upper buffer: 0.5 M Tris-HCl pH 6.8, 0.4% SDS
Lower buffer: 1.5 M Tris-HCl pH 8.8, 0.4% SDS
Triton X-100 lysis buffer: 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1 mM EDTA, 1%
Triton X-100
CoIP buffer: 150 mM NaCl, 20 mM Tris-HCl pH 7.4, 1 mM EDTA, 1% Nonidet P-40,
10% glycerol
5x SDS sample buffer: 12.5 ml upper buffer, 10 ml glycerol, 2 g SDS,
1 ml β-mercaptoethanol, bromophenol blue in 25 ml H2O
HHGN: 10% 10x HBSS-Hank’s buffered salt solution [-] calcium [-] magnesium, 2.5
mM HEPES pH 7.5, 35 mM glucose, 4 mM NaHCO3
Cbc: BME [+] Earle’s salts [-] L-Glutamine, 10% calf serum (heat inactivated, Hyclone),
1% PSG, 25 mM KCl
DnB: 500 µl DNase (2µg/µl), 10 ml BME [+] Earle’s salts [-] L-Glutamine
TDn: 250 µl DNase (2µg/µl), 5 ml HHGN, 50 mg Trypsin (Worthington)
2x HBSS: 4 g NaCl, 117.5 mg KCl, 95 mg Na2HPO4x7H2O, 675 mg Glucose, 2.5 g
HEPES-free acid in 250 ml H2O
Hippocampal neuron plating medium: DMEM [+] 4.5 g/l glucose [+] glutamine [+]
pyruvate, 10% FBS (Biochrom), 1% PSG, 0.0125 mM glutamate
Hippocampal neuron growth medium: Neurobasal medium, 2% B27 supplement,
1% PSG
HEK 293T medium: DMEM [+] 4.5 g/l glucose [-] glutamine [-] pyruvate, 10% FBS,
1% GlutaMAX®
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8% PFA: 375 ml sterile H2O at 60◦C, 40 g PFA, 50 ml 10% PBS, 40 g sucrose, set pH to
7.4, fill up with sterile H2O to 500ml
Mounting medium: 6 g glycerol AR, 2.4 g Mowiol 4-88 (Calbiochem), 6 ml H2O, 12
ml 0.2 M Tris-HCl pH 8.5
2x TAE: 80 mM Tris-acetate, 2 mM EDTA pH 8.5
2x YT (1000 ml): 16 g tryptone, 10 g yeast extract, 5 g NaCl
Tail lysis buffer: 200 mM NaCl, 10 mM Tris pH 8.0, 10 mM EDTA, 0.5% SDS
Annealing buffer: 100 mM potassium acetate, 30 mM HEPES-KOH pH 7.4, 2 mM
magnesium acetate
Buffer A: 10 mM HEPES, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA
Buffer A+: Buffer A, 0.1% Nonidet P-40
NP-40 lysis buffer: 1 mM HEPES pH 7.2, 0.5% NP-40, 0.5 mM magnesium chloride,
0.1% β-mercaptoethanol
2.6. Expression constructs and primers
Constructs 1-6 and 13-20 were cloned by Dr. J. Stegmüller, 9, 10 - by N. Schwedhelm-
Domeyer, 8 - by C.Mukherjee and 22 - by D. Brockelt. For details concerning generation
of plasmids - see Section 2.7
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No. Construct Species Primers Restriction sites
1 pEGFP-C2-FBXO41 mouse EcoRI, BamHI
2 pEGFP-C2-FBXO41 aa35-873 mouse EcoRI, BamHI
3 pEGFP-C2-FBXO41 aa317-873 mouse EcoRI, BamHI
4 pEGFP-C2-FBXO41 aa355-873 mouse EcoRI, BamHI
5 pEGFP-C2-FBXO41 aa594-873 mouse EcoRI, BamHI
6 pEGFP-C2-FBXO41 aa1-546 mouse EcoRI, BamHI
7 pEGFP-C2-FBXO41 ∆CTR mouse 18031/17768/
17769/18032
EcoRI, BamHI
8 pEGFP-C2-FBXO41 ∆F-box mouse 19426/
19427
EcoRI, BamHI
9 pCMV-myc-FBXO41 mouse 18556/18552 KpnI, BglII
10 pCMV-myc-FBXO41 ∆CTR mouse 18556/18552 KpnI, BglII
11 pCMV-myc-FBXO41-Res mouse 19036/19037 KpnI, BglII
12 pCMV-myc-FBXO41-Res ∆CTR mouse 19036/19037 KpnI, BglII
13 pBluescript-U6-FBXO41 RNAi#1 rat, mouse 14211/14212 ApaI, EcoRI
14 pBluescript-U6-FBXO41 RNAi#2 rat, mouse 14213/14214 ApaI, EcoRI
15 pBluescript-U6-FBXO41 RNAi#4 rat, mouse 16102/16103 ApaI, EcoRI
16 pBluescript-U6-FBXO41 RNAi#5 rat, mouse 16104/16105 ApaI, EcoRI
17 pBluescript-U6-FBXO41 RNAi#6 rat, mouse,
human
20264/20265 ApaI, EcoRI
18 pBluescript-U6-FBXO41 RNAi#8 rat, mouse,
human
20268/20269 ApaI, EcoRI
19 FBXO41 RNAi#5-CMV-EGFP rat, mouse 16104/16105 SacI, SacII
20 pCMV-myc-Skp1 rat 15454/15455 XhoI, NotI
21 pCMV-myc-DISC1 human 22773/22774
22 pBluescript-U6-DISC1 RNAi rat, mouse,
human
17497/17498 ApaI, EcoRI




2.6. Expression constructs and primers
Expression plasmids listed below were obtained from external sources:
Construct Species Obtained from
myc-FBXO31 human David Callen, University of Adelaide
pcDNA 3.1-Flag-DISC1 human Kirsty Millar, University of Edinburgh
Flag-Cullin7 Zhen-Qiang Pan,eMount Sinai School
of Medicine, New York
pIRES-hrGFP-1a-Flag-NDEL1 human Minh Dang Nguyen, University of Cal-
gary
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2.7.1. General molecular cloning
For cloning into an expression vector, a desired cDNA sequence was amplified using
primers listed in Section 2.6. e PCR reactionwas performed according to tables below.




1 µl forward primer
1 µl reverse primer
1 µl template DNA (100ng/µl)
5 µl 10x reaction buffer + Mg
0.6 µl dNTPs (25 mM)






30 cyclesX◦C 30 s
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PCR product was electrophoretically separated on an agarose gel to assess its size and
quality. DNA fragment of a correct size was subsequently excised from the gel, purified
with the NucleoSpin® Gel and PCR Clean-up kit and eluted in 40 µl of water.
e entire purified PCR product (insert) and 3 µg of target expression vector were
digested with restriction enzymes listed in Section 2.6, in a volume of 50 µl. Digested
vector was additionally treated for 1 hour with 10 units of calf intestinal phosphatase
(CIP) to remove the 5’ phosphate group and prevent religation. Following CIP treat-
ment, the vector was subjected to electrophoresis on an agarose gel to separate the lin-
earized fraction, which was then extracted with the NucleoSpin® Gel and PCR Clean-up
kit and eluted in 40 µl water. e insert was purified with the same kit, directly aer
digestion. 28 µl of water was used for insert elution.
Subsequent ligation of insert (5 µl) and vector (1 µl) was performed using 5 units
of T4 DNA ligase over night at 16◦C. e next day, the entire volume of the reaction
was used to transform chemically competent DH5α strain of E.coli. Aer addition of
the DNA mixture, the bacteria were incubated on ice for 20 min, following by a 1 min
heat shock at 42◦C. Next, bacteria were cooled down on ice for 2 min and 500 µl of
room temperature 2x YT media without antibiotics was added. Bacteria were then in-
cubated with shaking at 37◦C for 1 hour, spun down at 4000 rpm for 5 min and plated
on prewarmed 2x YT agar plates containing appropriate antibiotic.
e result of the ligation was assessed by digesting the mini-preparation of plasmids
(obtained using the NucleoSpin® Gel and PCR Clean-up kit) with the enzymes used for
cloning and by sequencing of positive clones.
2.7.2. Generation of vector-based shRNA
ShRNA generated for this study were in pBluescript vector containing a U6 promoter.
Oligonucleotides used to clone the shRNA are listed in Section 2.6. 2 µl of the sense
and antisense oligonucleotide (50 pmol/µl) were first diluted in 46 µl annealing buffer
and incubated at 95◦C for 4 min, at 72◦C for 10 min and finally cooled down to room
temperature at a rate of 0.1◦C/min. 20µl of the reaction mixture was phosphorylated
using polynucleotide kinase (PNK). At the same time, pBluescript-U6 vector was di-
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gested with ApaI, treated with T4 DNA polymerase to obtain blunt ends following by
digestion with EcoRI and dephosphorylation by calf intestinal phosphatase. Vector and
annealed oligonucleotides were ligated over night at 4◦C. Positive clones were iden-
tified by digestion with HpaI (introduced oligonucleotides contained the appropriate
restriction site) and verified by sequencing.
2.7.3. Site-directed mutagenesis
Rescue constructs for this study were generated by site-directed mutagenesis using
the ickChange® Site-Directed Mutagenesis Kit (Agilent Technologies) according to
the manufacturer instructions. First, the PCR reaction was performed as shown in the
following tables (primer sequences are provided in Section 2.6):
Reaction setup
Volume Reagent
1,5 µl forward primer (10 pmol/µl)
1,5 µl reverse primer (10 pmol/µl)
1 µl plasmid DNA (10 ng/µl)
5 µl 10x reaction buffer [+] Mg
1 µl dNTPs (25 mM)






18 cycles55◦C 1 min
68◦C 1 min/ 500 bp of template
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Next, the reaction mix was incubated on ice for 2 min and digested with DpnI to re-
move the non-mutated parental DNA strand. 1 µl of the digested sample was used to
transform the DH5α E.coli, which were subsequently plated on prewarmed 2x YT agar
plates. Obtained clones were subjected to sequencing to validate successful mutagene-
sis.
2.7.4. Generation of deletion mutants (∆CTR and ∆F-box)
Deletion mutants used in this study were generated by performing two separate PCR
reactions to amplify the fragment form the START codon until just before the deletion
domain and from just aer the deletion domain until the STOP codon. In the second
step, a final PCR was performed to fuse both fragments, resulting in a protein lacking
a specific region. Fusion of both fragments was possible because the primers harbor
a sequence generating complementary overhangs on both sides of the domain to be
deleted.
Reaction setup to generate the N- and C- terminal fragments and fusion PCR setup
are shown in the following tables (for the PCR conditions see Subsection 2.7.1):
PCR for N- and C-terminal fragments
Volume Reagent
1 µl forward primer (10 pmol/µl)
1 µl reverse primer (10 pmol/µ)
100 ng template DNA
5 µl 10x reaction buffer [+] Mg
0.6 µl dNTPs (25 mM)






1 µl forward primer (10 pmol/µl)
1 µl reverse primer (10 pmol/µl)
1 µl N-terminal fragment
1 µl C-terminal fragment
5 µl 10x reaction buffer [+] Mg
0.6 µl dNTPs (25 mM)
0.5 µl Pfu DNA polymerase (2.5 units/µl)
40.9 µl H2O
2.8. Cell culture
2.8.1. Culture of HEK 293T cells
HEK 293T cells were maintained in 10 cm dishes in DMEM supplemented with 10%
FBS and 1% GlutaMAX®. When approx. 90% confluent, cells were split. erefor the
cells were first washed with PBS and incubated with 2 ml 1x TE (10 mM Trypsin pH
8.0 and 1 mM EDTA) for 5 min at 37◦C. Subsequently, 8 ml of the HEK 293T medium
was added to inactivate the trypsin and the cells were detached from the plate by pipet-
ting the liquid up and down. Cell suspension was centrifuged at 4◦C, 800 rpm for 5
min, resuspended with HEK 293T medium and plated on 6-well plates for biochemical
experiments or 10 cm plates for maintaining the cell line.
2.8.2. Culture of primary cerebellar granule neurons
Cerebella were isolated from 6 days old Wistar rats or from P5 C57/BL6 mice and
collected into the HHGN medium kept on ice. Fine forceps were used to remove the
meninges under a dissection microscope. Next, the cerebella were washed 3 times with
HHGN and incubated with 4 ml of TDn for 10 min at 37◦C and another 10 min at RT.
Digested tissue was again subjected to 3 HHGN washes and triturated in 4 ml of DnB
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until the suspension appeared homogenous. Following 5 min incubation on ice, the su-
pernatant was transferred to a fresh conical tube. e remaining tissue was triturated
again with another 4 ml of DnB and combined with the first part of the supernatant.
e cell suspension was centrifuged at 4◦C, 800 rpm for 5 min and the pellet was re-
suspended in 20 ml of Cbc medium. Neurons were counted in a hemocytometer and
plated in Cbc medium on plates or coverslips (12 mm,ermo Fisher) coated with poly-
ornithine. For coating the plates or coverslips, a 15 µg/ml polyornithine solution was
applied for 30 min at 37◦C, followed by 2 washes with sterile H2O. 20 x 106 neurons
were plated on 24-well plates, 30 x 106 on 6-well plates and 50 x 106 on 10 cm plates.
On DIV 1, a mitotic inhibitor (Arabinofuranosyl Cytidine, Ara-C) was added directly to
the culture medium at a final concentration of 10 µM. Every 3rd day the medium was
supplemented with 35 mM glucose.
2.8.3. Culture of primary hippocampal neurons
Hippocampi of E18 Wistar rat embryos were isolated in HBSS ([-] calcium [-] mag-
nesium, Gibco) under the dissection microscope and collected in the HBSS medium on
ice. Following 3 washes with HBSS the volume was reduced to 1.8 ml and 200 µl of TE
(0.05%, Gibco) was added. e hippocampi were incubated at 37◦Cfor 10 min. Next, the
tissue was again washed 3x with HBSS and triturated in 1 ml of hippocampal neuron
plating medium with freshly added 50 µl DNase (2 mg/ml). Cell suspension was spun
down at 4◦C, 800 rpm for 5 min and neurons were plated at a density of 50 000/well in a
24-well plate with coverslips. Coverslips were pre-coated with 0.00083% poly-L-lysine
for 2h at 37◦C, washed 2x with H2O and incubated with HBSS until needed. One day
aer plating the medium was changed to the hippocampal neuron growth medium.
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2.9. Calcium phosphate transfection
2.9.1. Transfection of HEK 293T cells
HEK 293T cells were transfected in 6-well plates at a confluency of approx. 70-80 %.
For transfecting of 1 well, plasmid DNA was diluted in water to the volume of 90 µl.
Next, 10 µl 2.5 M calcium chloride was added and mixed well by pipeing, followed
by addition of 100 µl of 2x HBSS. e mixture was then incubated at RT for 5 min and
added to the cells.
2.9.2. Transfection of primary neurons
Cerebellar granule neurons and hippocampal neurons were transfected in 24-well
plates. First, the neurons were washed twice with DMEM [+] 4.5 g/l glucose [-] glu-
tamine [-] pyruvate and incubated with this solution for 30-45 min. e conditioned
culture medium was collected and stored at 37◦C for further use. In the meantime, the
DNA precipitates were prepared. For 1 well, DNA was diluted in water to a volume of
18 µl and 2 µl of 2.5 M calcium chloride as well as 20 µl 2x HBSS were added. Aer
20 min incubation, DNA precipitates were added to the neurons. 5-18 minutes later,
neurons were washed twice with DMEM [+] 4.5 g/l glucose [-] glutamine [-] pyruvate
and the conditioned culture medium was replaced.
2.10. Immunocytochemistry
HEK 293T cells or primary neurons were washed twice with PBS and fixed with 4%
PFA for 10 minutes. Aer another 2 washes with PBS, cells were permeabilized for 10
min with 0.4% Triton X-100 diluted in PBS. Subsequently the permeabilizing solution
was removed by washing twice with PBS and a blocking buffer was applied (BME + 10%
horse serum) for 30 min. In the next step, the cells were incubated either for 1 h at RT
or overnight at 4◦C with the primary antibody diluted in the blocking buffer. Aer 2
washes with the blocking buffer, the secondary, fluorophore-coupled antibody diluted
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in blocking buffer was added and incubated for 30-45 min. Aer 2 PBS washes, the
cells were incubated for 5 min with a DNA dye (bisbenzimide Hoechst 33258 or 4’,6-
diamidino-2-phenylindole - DAPI), washed twice with PBS and mounted with Mowiol
mounting medium on microscope slides (Marienfeld). Unless otherwise stated, all steps
were performed at RT.
2.11. Morphometrical analysis
Cerebellar granule neurons or hippocampal neurons were transfected with 1-2 µg of
expression plasmid, 0.3 µg of transfection marker (pEGFP C1 vector) and 0.4 µg Bclxl
(antiapoptotic protein). 3 (for the gain-of-function studies) or 4 (for the loss-of-function
experiments) days following the transfection, neurons were fixed and stained with the
GFP antibody as described in Section 2.10. Images of at least 30 neurons were acquired
in a blinded manner using fluorescent microscope Eclipse Ti and NIS-Element soware
(Nikon). Axon length and total dendrite length were measured by manual tracing of
the processes using Fiji (NIH) soware. Dendrite complexity was assessed with a Sholl
Analysis plugin of ImageJ (NIH).
2.12. Biochemical methods
2.12.1. Tissue lysate preparation
Mouse or rat tissues were isolated from animals sacrificed by decapitation or CO2
inhalation. Tissues were then placed in ice-cold Triton X-100 lysis buffer with freshly
added protease inhibitors (1 mMDTT, 1 µg/ml pepstatin, 3 µg/ml aprotinin and 1 µg/ml
leupeptin) and mechanically disrupted using 2 ml Dounce homogenizer or tissue dis-
persing instrument (Ultra Turrax, IKA®). Following 30 min incubation on ice, the sam-
ples were centrifuged for 10 min at 13 000 rpm, at 4◦C and the supernatant was either
used for further experiments or flash-frozen in liquid nitrogen.
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2.12.2. Preparation of cell lysates
Culture medium was aspirated from HEK 293T cells or primary neurons growing in
culture plates and the cells were washed with PBS. Next, the Triton X-100 lysis buffer
freshly supplemented with protease inhibitors (1 mM DTT, 1 µg/ml pepstatin, 3 µg/ml
aprotinin and 1 µg/ml leupeptin) was added, the cells were removed from the culture
dish using a cell scraper and collected in a reaction tube. Samples were incubated on
ice for 30 min and centrifuged for 10 min at 13 000 rpm, at 4◦C.
2.12.3. Bradford assay
e concentration of proteins in tissue or cell lysates was determined using Bradford
assay, where protein binding to Coomassie Brilliant Blue G-250 causes its absorbance
shi. Bovine serum albumin - BSA (4, 6, 8, and 10 µg for a standard curve) or a protein of
interest was added to 1 ml of the Bradford reagent (Bio Rad) diluted 5x in PBS. Samples
were mixed and the absorbance was measured at the wave length of 595 nm. Protein
concentration was calculated based on the BSA standard curve.
2.12.4. SDS-PAGE and western blot
Polyacrylamide gels used for SDS-PAGE were prepared in a gel casting system from
Bio-Rad according to the following table:
Reagent Separating gel (10%)/Stacking gel (3.9%)
30% acrylamide 5/0.65 ml




Cell or tissue lysates containing 30-100 µg proteins were mixed with the 5x SDS sam-
ple buffer and incubated at 95◦C for 5 min. Aer loading on the polyacrylamide gel,
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the samples were subjected to electrophoresis at 35 mA per gel. Next the proteins were
transferred onto a nitrocellulose membrane by a wet transfer at 300 mA for 90 min.
Following the transfer, the membrane was blocked with 4% milk powder in PBST for 30
min at RT. Subsequently, 3 PBST washes, 10 min each, were applied and the membrane
was incubated with a primary antibody for 1 h at RT or overnight at 4◦C. Primary
antibodies were diluted either in 3% BSA with 0.02% NaN3 or in 4% milk powder in
PBST. Aer 3 more PBST washes, the membrane was incubated for 30 min at RT with
a secondary antibody coupled to horseradish peroxidase (HRP), diluted in PBST sup-
plemented with 4% milk powder. e membrane was then subjected to 3 final PBST
washes and incubated shortly with the enhanced chemiluminescent (ECL) horse radish
peroxidase substrates (ermo Scientific, Bonn). Next, an X-ray film was exposed to
the membrane and developed in a dark room.
2.12.5. Co-Immunoprecipitation (CoIP)
For coimmunoprecipitation experiments, transfected HEK 293T cells were lysed as
described in Section 2.12.2 but the CoIP buffer was used instead of the Triton X 100 ly-
sis buffer. 10% of the samples was set aside as an input control and the remaining lysates
were rotated with an approx. 1 µg of an appropriate antibody for 4 h or overnight at
4◦C. Subsequently, 20 µl of protein A-sepharose beads were added to every sample and
rotated at 4◦C for another hour. Protein A-sepharose beads used for this step were first
washed twice with the CoIP buffer and stored in equal amount of CoIP buffer at 4◦C un-
til used. Following incubation with protein A-sepharose beads, the samples were spun
down at 10 000 rpm for 30 s and the supernatant was removed. Remaining beads with
bound proteins were washed 3x with the Triton X-100 lysis buffer and once with PBS,
next the PBS was removed leaving approx. 10 µl of the liquid inside and the samples
were incubated at 95◦C for 5 min with 30 µl of SDS sample buffer. e immunoprecip-
itates and inputs were further used for SDS-PAGE and western blot.
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2.12.6. Subcellular fractionation
CGNs from 2 wells of a 6-well plate were washed with PBS and lysed with buffer
A supplemented with protease inhibitors (0.5 mM PMSF, 5-10 µg/ml aprotinin and 5
mM N-ethyl maleimide (NEM)). Samples were then incubated on ice for 15 min and the
cells were mechanically disrupted using a 2 ml Dounce homogenizer. Next, the lysates
were centrifuged at 2000 rpm for 5 min at 4◦C and the supernatant (also: postnuclear
supernatant, PNS) was collected and kept for further use. e pellet was washed 3x
with buffer A+ and resuspended with 50 µl of Buffer C followed by rotating for 15 min
at 4◦C. Subsequently, the samples were centrifuged at 14,000 rpm for 20 min and the
supernatant was used as nuclear fraction (NF). PNS andNFwere subjected to SDS-PAGE
and western blot.
2.12.7. Centrosomal purification
One hour before the lysis, CGNs were treated with cytochalasin D (1 µg/ml) and
nocodazole (0.2 µM). Aer the treatment, neurons were lysed in the NP-40 lysis buffer
supplemented freshly with protease inhibitors (1 µg/ml pepstatin, 1 µg/ml aprotinin, 1
µg/ml leupeptin and 1 mM PMSF). Next, the lysates were centrifuged with 60% sucrose
at 10000g for 30 min at 4℃, the boom fraction containing concentrated centrosomes
was loaded onto a discontinuous sucrose gradient: 40%, 50% and 70%, and centrifuged
at 34000g for 1 h at 4℃. FBXO41 was immunoprecipitated from the collected fractions
and used for SDS-PAGE and western blot.
2.13. In vivo electroporation, immunohistochemistry
and data analysis
In vivo electroporationwas performed on P4Wistar rats as previously described (Kon-
ishi et al., 2004). 16 µg of plasmid DNA and 4 µg of Bclxl in a volume of 3 µl, together
with 0.03% Fast Green, were injected per cerebellum with a 30 gauge needle. Next, the
animals were subjected to 4 electrical pulses (160-170 V for 50 ms, 950 ms interval) and
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returned to the dam. At P9, the animals were sacrificed and isolated cerebella were
immersed in 4% PFA diluted with PBS and incubated at 4◦C with gentle rocking. e
next day the cerebella were washed twice with PBS and 30% sucrose solution in PBS
was added. Aer the cerebella sank to the boom of the tubes, they were mounted into
plastic molds using OCT (Tissue Tek, Sakura, Torrance, CA) and 30% sucrose in PBS,
both mixed in equal proportions. e mounting solution was allowed to solidify on dry
ice and the cerebella were stored at -80◦C. For further analysis, cerebella were cut into
40 µm thin sections and the mounting medium was removed by washing with PBS for
10 min. Next, the section were incubated for 30 min with a blocking buffer (10% normal
goat serum, 2% BSA, 0.4% Triton X-100 in PBS). Subsequently, the mouse GFP antibody
diluted in 2% BSA in PBS and 0.4% Triton X-100 was applied overnight at 4◦C. Following
2x PBS wash, slides were incubated with the secondary antibody (anti-mouse Alexa 488
diluted in 2% BSA, 0.4% Triton X-100 in PBS) for 2 h. Slides were washed twice with PBS
prior to incubation with Hoechst 33258 for 5 min. Mowiol mounting medium was used
for mounting a glass cover slip on a slide. Pictures of cerebellar sections were acquired
with a fluorescent microscope Eclipse Ti (Nikon) or a confocal SP2 (Leica) microscope
in a blinded manner. Analysis of localization of CGNs in a particular cerebellar layer
or measurement of migrated distance was performed with the Fiji soware (NIH).
2.14. Generation of an FBXO41 knockout mouse
eFBXO41 knockout ES cells were from aC57/BL6mouse andwere generated by the
KOMP repository. In these cells, the whole FBXO41 gene was replaced by a β-galacto-
sidase cassee and a neomycin resistance gene under the human ubiquitin C promoter.
e ES cells were then injected to a blastocyst from a C57/BL6 mouse. Chimeric animal
obtained aer injection of the blastocyst to a foster mother, was crossed with a wild
type animal and a germline transmission was achieved. Genotyping of the mouse line
was performed as follows:
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Genotyping PCR setup
Volume Reagent
1 µl forward primer (10 pmol/µl)
1 µl reverse primer (10 pmol/µl)
5 µl 5x GoTaq® buffer
2.1 µl dNTPs (2.5 mM)












Primers listed below were used for the genotyping PCR:
Forward WT/KO: 5’ ATCCACCTAGACCTAGTAATCTTA 3’
Reverse WT: 5’ CTTCTCCAGGGCGCGGAT 3’
Reverse KO: 5’ AATGCGCTCAGGTCAAATTCAG 3
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2.15. Generation of the FBXO41 antibody
e rabbit polyclonal FBXO41 antibody was generated by Eurogentec. e antigen
was a short fragment of mouse FBXO41 expressed in BL21 E. coli and affinity-purified
using Ni-NTA Sepharose (Qiagen), since the antigen harbored a polyhistidine tag.
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3.1. Characterization of FBXO41 expression
3.1.1. FBXO41 is a CNS-specific neuronal protein
Growing evidence demonstrates the importance of F-box proteins in neurodevelop-
ment and pathogenesis of neurological disorders (Westbrook et al., 2008, Zhao et al.,
2011, Hoeck et al., 2010, Wu et al., 2013, Boix-Perales et al., 2007, Jandke et al., 2011,
Lierman et al., 2011, Saiga et al., 2009, Fonzo et al., 2009, Gong et al., 2010, Liao et al.,
2004). Owing to this fact, the aim of my study was to characterize novel F-box proteins
essential for brain development. A search of the Cerebellar Development Transcrip-
tome Database (CDT-DB) led to the brain-specific F-box protein FBXO41, whose spe-
cific expression in the cortex, hippocampus and cerebellum was confirmed by RT-PCR
(Fig. 3.1 A).
In order to examine FBXO41 expression at the protein level, I first verified the speci-
ficity of the custom made FBXO41 antibody by means of antigen competition. I used
tissue lysates from cortex and spleen, the laer serving as a negative control, and sub-
jected them to immunobloing either with the untreated FBXO41 antibody or with the
FBXO41 antibody, which was exposed to the antigen prior to incubation with the nitro-
cellulose membrane. While the antibody on its own revealed a band of approximately
100 kDa, the antibody preincubated with the antigen failed to do so (Fig. 3.1 B). Us-
ing this specific FBXO41 antibody, I demonstrated that FBXO41 was expressed in the
mouse brain (cortex, cerebellum and hippocampus), but not in the lung, liver, heart,
kidney, spleen and testis (Fig. 3.1 C). Additionally, C. Mukherjee found that FBXO41
was expressed in the spinal cord but not in the sciatic nerve. ese finding revealed
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Figure 3.1.: FBXO41 is a brain-specific neuronal protein. (A) FBXO41 mRNA was
isolated from a P20 mouse and cDNA was synthesized. RT-PCR was performed with
primers located in FBXO41 and GAPDH cDNA. e laer was used as an internal con-
trol. e experiment was conducted by Dr. R. Busse. (B) Lysates frommouse cortex and
spleen were immunobloed with the FBXO41 antibody alone or with with the FBXO41
antibody preabsorbed with the antigen. Pan 14-3-3 was used as a loading control. As-
terisks indicate non-specific bands. (C) Indicated tissues from a P20 mouse were lysed
and subjected to immunobloing with the FBXO41 antibody and the pan 14-3-3 an-
tibody served as a loading control. (D) Lysates from cultured CGNs, astrocytes and
oligodendrocytes were probed with the FBXO41 antibody as well as the GFAP and PLP
antibodies, which served as positive controls for astrocytes and oligodendrocytes, re-
spectively. γ-Tubulin antibody was used as a loading control.
that FBXO41 is a central nervous system-specific protein.
Having established that FBXO41 is exclusively expressed in the brain, I went on to
investigate the expression of FBXO41 in different cell types present in the CNS. For
this purpose, I prepared total lysates from cultured cerebellar granule neurons (CGNs),
astrocytes and oligodendrocytes, which I subsequently subjected to immunobloing
with the FBXO41 antibody (Fig. 3.1 D). I found that only neurons but neither astrocytes,
nor oligodendrocytes express FBXO41. e analysis supports the notion that FBXO41
is a neuron-specific protein.
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3.1.2. FBXO41 is expressed in embryonic and adult brain tissues
To answer the question if FBXO41may play an important role in brain development, it
was essential to characterize its temporal expression paern. For this purpose, I isolated
heads from E10, total brain from E12 or cortices from E14, 16 and 18 mouse embryos
and subjected the lysates to immunobloing with the FBXO41 antibody. I found that
FBXO41 was already detectable in the E10 embryo and its expression increased during
the embryonic development (Fig. 3.2 A). Moreover, I examined FBXO41 expression in
the cortex, cerebellum and hippocampus of older mice (E18 to P60). ese data show
that FBXO41 was expressed at all time points analyzed and its amount increased with
the age in the cerebellum and hippocampus (Fig. 3.2 B).
Figure 3.2.: FBXO41 is expressed from embryonic stages to adulthood. (A, B) Lysates
from indicated tissues were isolated from E10-P60 mice and immunobloed with the
FBXO41 or the pan 14-3-3 antibodies. e laer served as a loading control.
3.1.3. FBXO41 is expressed in cultured neurons
Since cultured neurons are an excellent model system to investigate protein function
in the brain, I determined the expression of FBXO41 in cultured CGNs in addition to
cortical and hippocampal neurons. In order to do so, I harvested these neurons at dif-
ferent days in vitro (DIV). Subsequent immunobloing of the lysates with the FBXO41
antibody revealed that FBXO41 was present in all neuronal types and its expression
peaked around DIV 6 (Fig. 3.3), demonstrating that cultured neurons express FBXO41.
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Figure 3.3.: Cultured neurons express FBXO41. Lysates from cortical and hippocampal
neurons as well as from CGNs were prepared at indicated DIVs and probed with the
FBXO41 antibody. Pan 14-3-3 antibody was used as a loading control.
3.1.4. FBXO41 is localized to the centrosome and cytoplasm of
neurons
To dissect the expression of FBXO41 at the subcellular level, I transfected cultured
CGNs with a plasmid encoding GFP-FBXO41 and subjected the neurons to immuno-
staining with the GFP antibody. I found that FBXO41 was localized to the cytoplasm,
including axons and dendrites, and to the centrosome. Furthermore, FBXO41 was ab-
sent from the nucleus (Fig. 3.4 A). Further subcellular fractionation and centrosomal
purification analyses of CGNs verified FBXO41’s cytoplasmic localization and presence
at the centrosome, respectively (Fig. 3.4 B and C). Taken together, these results revealed
that FBXO41 is a cytoplasmic and centrosomal protein.
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Figure 3.4.: FBXO41 localizes to the centrosome and cytoplasm of cerebellar granule
neurons. (A) CGNs were transfected at DIV 2 with GFP-FBXO41 and subjected to im-
munostaining using the GFP antibody and the DNA dye 4’,6-diamidino-2-phenylindole
(DAPI) 1.5 days later. Arrowheads indicate axon, arrow indicates centrosomal FBXO41.
Scale bar: 20 µm. e image was taken by Dr. M. Vadhvani. (B) Subcellular fraction-
ation was performed using CGNs prior to immunobloing with the FBXO41 antibody.
Pan 14-3-3 and SnoN antibodies were used as controls for the postnuclear supernatant
(PNS) and the nuclear fraction (NF), respectively. Asterisk indicates a non-specific
band. is analysis was performed by Dr. M. Kannan. (C) CGNs were subjected to
centrosomal purification followed by immunoprecipitation with the FBXO41 antibody.
Immunoprecipitates were probed with the FBXO41 antibody. γ-Tubulin served as a
positive control for the centrosomal fraction. e experiment was conducted by N.
Schwedhelm-Domeyer.
3.2. Functional analysis of FBXO41 in the neural
development
Based on FBXO41 expression in the developing brain and its centrosomal localization,
we reasoned that FBXO41 may play an essential role in neurodevelopmental processes
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like neuronal morphogenesis, migration and survival. In this study, I used gain- and
loss-of-function approaches to elucidate the function of FBXO41 in axon and dendrite
growth, establishment of neuronal polarity, migration and survival.
3.2.1. The role of FBXO41 in neuronal morphogenesis
3.2.1.1. Knockdown of FBXO41 in CGNs inhibits axon growth
To examine the role of FBXO41 in neuronal morphology, I took an RNAi approach,
for which I first tested the efficacy of a set of FBXO41 RNAi plasmids generated in
the lab (Fig. 3.5 A). Here, I transfected HEK 293T cells with the myc-FBXO41 plasmid
together with different FBXO41 RNAi plasmids and subjected lysates, obtained 4 days
later, to immunobloing. e experiment indicated that FBXO41 RNAi#5 efficiently
downregulated FBXO41 expression (Fig. 3.5 B).
Figure 3.5.: RNAi#5 efficiently knos down FBXO41. (A) Schematic of FBXO41 with
indicated domains as well as RNAi targeting regions. (B) HEK 293T cells were trans-
fected with myc-FBXO41 and U6 empty control vector or RNAi plasmids: #1, #2, #4, #5,
#6 and #8. Aer 4 days, cell lysates were immunobloed with the myc antibody. Pan
14-3-3 served as a loading control.
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In the next step, I transfected cultured CGNs at DIV 0 with the empty control plasmid,
the functional FBXO41 RNAi#5 or the non-functional FBXO41 RNAi#2 and analyzed
neuronal morphology 4 days later. I found that FBXO41 knockdown resulted in signi-
ficantly shorter axons as compared to the control condition (Fig. 3.6). Expression of the
non-functional FBXO41 RNAi in turn had lile or no effect on axon growth (Fig. 3.6).
is experiment indicates that FBXO41 promotes axon growth in cerebellar granule
neurons.
Figure 3.6.: FBXO41 RNAi inhibits axon growth. (A) CGNs transfected at DIV0 with
empty U6 vector, FBXO41 RNAi#2 (non-functional) or #5 (functional) and a GFP-
encoding plasmid were immunostained with the GFP antibody 4 days later, followed
by morphological analysis. A total of 431 neurons were measured (ANOVA, *p<0.05,
ns= non-significant, mean + s.e.m.). (B) Representative images of (A). Arrows indicate
axons. Scale bar: 100µm.
To exclude possible off-target effects of FBXO41 RNAi, I conducted a rescue experi-
ment, for which I generated an FBXO41-Res mutant by introducing 4 silent mutations
into the RNAi#5 targeting region of FBXO41, with site-directed mutagenesis (Fig. 3.7
A). en I co-transfected HEK 293T cells with the empty U6 vector together with the
myc-FBXO41 WT as a control condition and the FBXO41 RNAi#5 together with either
empty myc vector or FBXO41-Res expression plasmid. Four days later, I analyzed the
lysates using immunobloing and observed that the levels of the FBXO41-Res but not
of the wild type FBXO41 were restored when RNAi#5 was co-expressed. is result




Figure 3.7.: FBXO41-Res is resistant to RNAi-induced knodown. (A) Silent muta-
tions in the targeting region of FBXO41 are indicated in red. (B) HEK293T cells were
transfected with indicated plasmids and lysed 4 days later. Lysates were immunobloed
with the myc antibody and the pan 14-3-3 antibody for loading control.
I subsequently transfected CGNs at DIV 0 with the empty control U6 and myc vec-
tors or with the FBXO41 RNAi#5 together with either the empty myc vector or myc-
FBXO41-Res and fixed the cells 4 days later. Morphometric analysis revealed that the
axon length is reduced upon the FBXO41 knockdown, but can be restored to baseline
of control condition by overexpressing the RNAi-resistant mutant of FBXO41 (Fig. 3.8).
e experiment established FBXO41 as a regulator of axon growth in CGNs.
Figure 3.8.: FBXO41-Res overexpression restores axon growth in FBXO41 knodown
CGNs. (A) CGNs transfected at DIV0 with empty U6 and pCMV-myc vectors (control)
or FBXO41 RNAi#5 together with either pCMV-myc or FBXO41-Res were morphome-
trically analyzed at DIV 4. 621 neurons were measured (ANOVA, ***p<0.001, mean +
s.e.m.). (B) Representative images of (A). Arrows indicate axons. Scale bar: 100µm.
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3.2.1.2. Axon growth is reduced in CGNs of FBXO41 knockout mice
To study the role of FBXO41 in brain development in vivo, we generated an FBXO41
knockout (KO) mouse, in which the entire FBXO41 gene was deleted and replaced by a
β-galactosidase reporter cassee and neomycin selection cassee (Fig. 3.9 A). For the
genotyping PCR, specific sets of primers were designed to detect the wild type and the
mutant allele (Fig. 3.9 B).
Figure 3.9.: FBXO41 KO mouse generation strategy. (A) In ES cells purchased from
KOMP, the entire FBXO41 gene was replaced by a β-galactosidase encoding sequence
and a neomycin resistance gene under the human ubiquitin C promoter. (B) Repre-
sentative genotyping PCR of mice following germline transmission. Location of the
primers is indicated in (A).
Upon proper germline transmission, I verified the deletion of FBXO41 by subjecting
lysates from P5 and P16 FBXO41+/+, FBXO41+/− and FBXO41−/− cortex, cerebellum
and hippocampus to immunobloingwith the FBXO41 and the β-Gal antibody. FBXO41
is completely absent from the KOmice. In heterozygous FBXO41 KO brains, I found half
of the amount as compared to wild type mice. Conversely, while β-Gal was absent from
wild type brain, I detected increasing amounts in heterozygous and homozygous brains
(Fig. 3.10). In addition, the β-Gal expression paern goes in line with the previous
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observations that FBXO41 is present in the cortex, cerebellum and hippocampus. is
finding confirms the efficient ablation of FBXO41 and a successful integration of the
reporter cassee.
Figure 3.10.: Successful deletion of FBXO41 in the brain. Lysates from cortex, hip-
pocampus and cerebellum of P5 and P16 mice were immunobloed with the FBXO41
and the β-Gal antibody. γ-Tubulin served as a loading control.
Having established the levels of FBXO41 in wild type, heterozygous and homozygous
brains, I analyzed axonal growth in cultured cerebellar granule neurons isolated from
P5 pups of the aforementioned genotypes. At DIV 2, I transfected the neurons with the
GFP expression plasmid to visualize their morphology. Six days later, I measured the
axonal length. I discovered that axons of FBXO41−/− CGNs were significantly shorter
than the axons of the wild type neurons. Furthermore, axons of the heterozygous CGNs
had an intermediate length (Fig. 3.11). ese results indicate that FBXO41 stimulates
axon growth.
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Figure 3.11.: Axon growth is reduced in the CGNs from FBXO41 knoout mouse.
(A) CGNs from the FBXO41+/+, FBXO41+/− and FBXO41−/− mice were transfected
with a GFP-encoding plasmid at DIV 2 and immunostained with the GFP antibody at
DIV 8. Axons of 908 neurons were measured (ANOVA, ***p<0.001, mean + s.e.m.). (B)
Representative images of (A). Arrows indicate axons. Scale bar: 100µm.
Further, I performed a rescue experiment, in which I expressed FBXO41 in FBXO41
knockout CGNs and compared the axon length with the FBXO41 wild type and knock-
out neurons, both transfected with the empty myc plasmid (Fig. 3.12) .
Figure 3.12.: Overexpression of FBXO41 rescues axon growth in the FBXO41−/−
neurons. (A) FBXO41+/+ CGNs were transfected with the pCMV-myc vector and
FBXO41−/− CGNs with the pCMV-myc vector or myc-FBXO41 together with a GFP
plasmid. Axon length was measured at DIV8. A total of 693 neurons was measured
(ANOVA, ***p<0.001, mean + s.e.m.). (B) Representative images of (A). Arrows indicate
axons. Scale bar: 100µm.
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Consistent with previous results, axon length was reduced in the KO CGNs but axon
growthwas restored in the KOneurons overexpressing FBXO41 . us, the axon growth
impairment is due to the loss of FBXO41 (Fig. 3.12).
3.2.1.3. Overexpression of FBXO41 promotes axon growth in CGNs
While the preceding experiments established a role for FBXO41 in axon growth of
cerebellar granule neurons, I addressed whether FBXO41 gain-of-function would reveal
the opposite phenotype. erefore, I transfected CGNs at DIV 0 with the empty vector
or the FBXO41 expression plasmid and analyzed axon length 3 days later. I observed
significantly longer axons upon FBXO41 overexpression as compared to the control
(Fig. 3.13). is experiment established, that gain-of-function of FBXO41 promotes
axon growth of CGNs.
Figure 3.13.: Overexpression of FBXO41 promotes axon growth in CGNs (A) FBXO41
were transfectedwith the empty pCMV-myc plasmid orwithmyc-FBXO41 and the axon
length of 372 neurons was measured 3 days later (t-test, ***p<0.001, mean + s.e.m.). (B)
Representative images of (A). Arrows indicate axons. Scale bar:100µm.
3.2.1.4. FBXO41 controls axon growth independently of the neuronal subtype
To investigate if the FBXO41-regulated axon growth is a generalizable mechanism, I
isolated and cultured neurons from the E18 rat hippocampi and transfected them at DIV
1 with the empty control vector, the functional FBXO41 RNAi#5 or the non-functional
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FBXO41 RNAi#8. Morphological analyses at DIV5 revealed that the functional RNAi
causes the axons to grow significantly shorter than the non-functional RNAi or the
control vector (Fig. 3.14), which suggests that FBXO41 regulates axon growth in a neu-
ronal subtype-independent manner.
Figure 3.14.: Knodown of FBXO41 inhibits axon growth in hippocampal neurons.
(A) Hippocampal neurons were transfected at DIV1 with the control U6 vector or the
FBXO41 RNAi #5 and #8. Neurons were fixed 4 days later and the axon length was
measured. A total of 371 neurons was analyzed (ANOVA, ***p<0.001, mean + s.e.m.).
(B) Representative images of (A). Arrows indicate axons. Scale bar:100µm.
3.2.1.5. FBXO41-deficient neurons display proper dendrite growth and
axon-dendrite polarity
Having determined the role of FBXO41 in axon growth, I analyzed if it also plays a
role in dendrite growth and the establishment of neuronal polarity. First, I examined
the effect of FBXO41 loss-of-function on dendrite growth of CGNs transfected with the
empty U6 vector or the FBXO41 RNAi#5 at DIV 0. Four days later, I measured total
dendrite length and did not observe any significant difference between the knockdown
and the control neurons (Fig 3.15 A).
To further corroborate this result, I assessed the complexity of dendrites from cultured
FBXO41+/+ and FBXO41−/− cerebellar granule neurons using Sholl analysis. is ex-
periment also did not show any difference in the overall complexity of the wild type as
compared to knockout neurons (Fig. 3.15 B). ese results indicate that FBXO41 does
not control dendrite growth or branching.
Cultured hippocampal neurons represent a well-characterized system to study neu-
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Figure 3.15.: FBXO41 does not affect dendrite growth or complexity (A) CGNs were
transfected at DIV0 with the U6 control vector or the FBXO41 RNAi plasmid and an-
alyzed 4 days later. Total dendritic length of 352 neurons was measured (t-test, ns =
non-significant, mean + s.e.m.). (B) FBXO41+/+ and FBXO41−/− mouse CGNs were
transfected at DIV2 with a GFP plasmid and subjected to immunostaining with the GFP
antibody 6 days later. Dendrite complexity was assessed with the Sholl analysis using
ImageJ soware. 70 neurons were analyzed.
ronal polarity (Bartle et al., 1984, Doi et al., 1988, Caceres et al., 1984, Davis et al.,
1987, Bartle and Banker, 1984). Hence, I transfected hippocampal neurons with the
Figure 3.16.: FBXO41 is not required for establishment of neuronal polarity. (A) Hip-
pocampal neurons, transfected at DIV1 with the U6 control vector or with a functional
(#5) or non-functional (#8) FBXO41 RNAi together with a GFP plasmid, were subjected
to immunostaining with the GFP and MAP2 antibodies 4 days later. Percentage of neu-
rons with MAP2 expression restricted to dendrites and cell body was assessed. 364 neu-
rons were analyzed. (B) Representative images of (A). Asterisks indicate axons. Scale
bar: 100µm.
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FBXO41 RNAi#5, #8 or with the control U6 plasmid to asses if knockdown of FBXO41
changes the distribution of the somatodendritic marker, MAP2. I observed that in all
conditions, neurons exhibit MAP2 expression in the cell body and dendrites but not in
the axons, indicative of proper polarization (Caceres et al., 1984), (Fig. 3.16). e exper-
iment suggests that FBXO41 is not involved in the establishment of neuronal polarity.
3.2.2. FBXO41 promotes neuronal migration
During development, neurons not only undergo dramatic morphological changes, but
alsomigrate considerable distances to reach their destinations. Sincemany centrosomal
proteins like LIS1, DCX, DISC1 or NDEL1 have been reported to control neuronalmigra-
tion (Reiner et al., 1995, Sossey-Alaoui et al., 1998, Kamiya et al., 2005, Shu et al., 2004),
I was prompted to examine the role of FBXO41 in this process. To analyze FBXO41
in neuronal migration, I took advantage of the in vivo electroporation technique. Here,
plasmids were injected into the cerebella of P4 rat pups, which were subjected to electri-
cal pulses. Aer 5 days, migrating neurons of coronal cerebellar sections were analyzed.
In the developing cerebellum, granule neurons migrate in a radial manner, emanating
from the EGL, passing the ML and eventually seling in the IGL.
Figure 3.17.: FBXO41 RNAi bicistronic construct efficiently downregulates FBXO41.
(A) HEK 293T cells were transfected with the myc-FBXO41 plasmid and with U6-
cmvGFP empty vector or the FBXO41 RNAi-cmvGFP plasmid and lysed aer 4 days.
Lysates were immunobloed with the myc antibody. Pan 14-3-3 served as a loading
control.
Strikingly, I found that FBXO41 RNAi (Fig. 3.17) reduced neuronal migration. While
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more than 90% of control neurons migrated from the EGL through the ML into the
IGL, 42% of FBXO41 knockdown neurons were markedly stalled in the EGL/ML. ese
findings indicate that FBXO41 is required for neuronal migration.
e aforementioned finding is consistent with the results of histological analysis that
my colleague, C. Mukherjee, performed on P16 cerebella of wild type and homozygous
FBXO41 mice. P16 represents an age, in which the cerebellar lamination is completed.
e hematoxilin and eosin staining revealed proper development of wild type cerebella,
while the ML of FBXO41−/− cerebella displayed a residual EGL and neurons of elon-
gated shape, that did not complete their migration yet. is experiment indicates, that
FBXO41 is crucial for neuronal migation in vivo.
Figure 3.18.: FBXO41 regulates neuronal migration in the cerebellar cortex. (A) P4
rat cerebella were electroporated with the U6/EGFP control vector and the FBXO41
RNAi/GFP construct and isolated 5 days later. Coronal sections were immunostained
with the GFP antibody and the CGN cell bodies in each layer were counted. A total of
2347 neurons was analyzed (ANOVA, **p<0.01, ***p<0.001, ns = non-significant, mean
+ s.e.m.). EGL = external granular layer, ML = molecular layer, IGL = internal granular
layer. (B) Representative images of (A). Arrows indicate cell bodies. Scale bar: 50µm.
e in vivo electroporation was performed by Dr. J. Stegmüller and the confocal images
were taken by Dr. M. Vadhvani.
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3.2.3. Survival of P5 and P16 neurons is not affected by the loss
of FBXO41
FBXO41−/− mice exhibit high postnatal mortality and reduced bodyweight (Fig. 3.19)
as well as severe motor defects (C. Mukherjee, unpublished data). erefore, I used bio-
chemical methods to investigate if levels of proteins involved in apoptotic and survival
pathways are changed in these mice. First, I analyzed the expression of cleaved caspase
3 (CC3) in the FBXO41+/+, FBXO41+/− and FBXO41−/− P16 cortex and cerebellum,
and did not detect any change (Fig. 3.20 A, B). In the next step, I cultured FBXO41+/+,
FBXO41+/− and FBXO41−/− mouse CGNs and subjected them to 5 hours serum with-
drawal (starvation) at DIV4 to examine if loss of FBXO41 rendered neurons more sensi-
tive to stress-induced apoptosis. Subsequent immunobloing of lysates revealed equal
induction of CC3 expression (Fig. 3.20 C). Probing for the levels of phospho-ERK, total-
ERK, phospho-Akt and total-Akt in the FBXO41+/+, FBXO41+/− and FBXO41−/− mice
cortex and cerebellum led to similar negative results (Fig. 3.21). ese data indicate that
pathways regulating neuronal survival are not changed upon deletion of FBXO41.
Figure 3.19.: FBXO41−/− mice exhibit high mortality and reduced body and weight.
(A) Mortality of the FBXO41+/+, FBXO41+/− and FBXO41−/− mice was analyzed in
the first two postnatal weeks. (B, C) Body and brain weight of FBXO41 knockout mice
was assessed at indicated ages. At least 10 animals of each genotype were analyzed.
(ANOVA, **p<0.01, ***p<0.001, ns = non-significant, mean + s.e.m.).
67
3. Results
Figure 3.20.: FBXO41 knoout does not increase CC3 expression in mice. Lysates
from the P16 FBXO41+/+, FBXO41+/− and FBXO41−/− cortex and cerebellum (A, B)
or from CGNs deprived of serum for 5 hours (C) were immunobloed with the CC3
antibody. Lysates from CGNs aer 6 hours of serum deprivation served as a positive
control for the CC3 expression. γ-Tubulin was used as a loading control.
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Figure 3.21.: ERK and Akt pathways are not affected by the loss of FBXO41 in mice.
Levels of total Akt, total ERK, phospho-Akt and phospho-ERK were determined in the
lysates from P16 FBXO41+/+, FBXO41+/− and FBXO41−/− mice cortex and cerebellum
by immunobloingwith the indicated antibodies. γ-Tubulin served as a loading control.
3.2.4. Amino acids 179-354 direct FBXO41 to the centrosome
To investigate if the centrosomal localization of FBXO41 is essential for axon growth
or migration control, I first identified the region that targets FBXO41 to the centrosome.
I transfected both, HEK 293T cells and CGNs with a series of GFP-tagged FBXO41 dele-
tion mutants (Fig. 3.22 A). Subsequently, I subjected the cells to immunostaining with
the GFP antibody and observed that whenever the region between aa 179-354 is missing,
FBXO41 did not localize to the centrosome (Fig. 3.22 B). e experiment thus identified
this region of FBXO41 as the centrosome targeting region (CTR).
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Figure 3.22.: Amino acids 179-354 target FBXO41 to the centrosome. (A) Schematic
representation of various FBXO41 deletion mutants and their localization. e dele-
tion mutants were cloned by N. Schwedhelm-Domeyer. (B) HEK 293T cells or CGNs
were transfected with the GFP-tagged FBXO41 deletion mutants depicted in (A). Aer
2 days cells were subjected to immunostaining with the GFP antibody and the DNA dye
bisbenzimide Hoechst 33258. Arrows indicate centrosomes. Scale bar: 10 µm.
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3.2.5. FBXO41 regulates axon growth in a
centrosome-independent manner
To asses if centrosomal FBXO41 is responsible for promoting axon growth, I trans-
fected CGNs with empty vector or plasmids encoding wild type FBXO41 or FBXO41
∆CTR and measured axon length aer 3 days. Even though FBXO41 ∆CTR did not
localize to the centrosome, it still promoted axon growth to the extend of the wild
type FBXO41, suggesting that centrosomal localization is dispensable for the FBXO41-
mediated axon growth control (Fig. 3.23).
Figure 3.23.: Centrosomal localization is not required for the FBXO41-mediated axon
growth regulation. (A) CGNs were transfected with the full length or FBXO41 ∆CTR
as well as with the empty control vector and morphometrically analyzed aer 3 days.
A total of 849 neurons was measured (ANOVA, ***p<0.001, mean + s.e.m.). (B) Repre-
sentative images of (A). Arrows indicate axons. Scale bar: 100 µm.
In order to corroborate this result, I investigated if FBXO41∆CTR was able to rescue
the short axon phenotype caused by FBXO41 knockdown. For this purpose, I generated
and validated an RNAi-resistant FBXO41, lacking the CTR (Fig 3.24) and carried out an
axon growth assay, in which I expressed FBXO41-Res or FBXO41 ∆CTR-Res in the
background of FBXO41 knockdown. Morphometrical analysis revealed that expression
of both, wild type and ∆CTR rescue plasmids restored the axon length of the FBXO41
knockdown neurons to the control level (Fig. 3.25). is experiment demonstrated that
the acentrosomal FBXO41 promotes axon growth.
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Figure 3.24.: FBXO41∆CTR-Res is resistant to the RNAi against FBXO41. HEK 293T
cells were transfected with the indicated plasmids and lysed 4 days later. Lysates were
subjected to immunobloing using the myc antibody. Pan 14-3-3 served as a loading
control.
Figure 3.25.: FBXO41 ∆CTR rescues the effect of FBXO41 knodown on the axon
growth. (A) CGNs were transfected with the indicated plasmids and axon length was
measured 4 days later. 668 neurons were analyzed. (ANOVA, ***p<0.001, mean + s.e.m.).
(B) Representative images of (A). Arrows indicate axons. Scale bar: 100 µm.
3.2.6. Centrosomal FBXO41 promotes neuronal migration
In further in vivo electroporation analyses, I investigated if FBXO41 regulates neu-
ronal migration in a centrosome-dependent manner. Measurement of the migration
distance of CGNs, electroporatedwith control vector or plasmids encoding FBXO41WT
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or FBXO41 ∆CTR, showed that while the FBXO41 WT enhanced migration, FBXO41
∆CTR CGNs migrated significantly shorter distances than FBXO41 WT neurons but
significantly farther than control neurons (Fig. 3.26). is experiment suggests that the
centrosomal localization of FBXO41 is required for proper CGN migration.
Figure 3.26.: FBXO41 promotes neuronal migration in a centrosome-dependent man-
ner. (A, B) Cerebella of P4 rat pups were electroporated with control vector, FBXO41 or
FBXO41 ΔCTR plasmid together with pSyn-GFP expression plasmid. 5 days later cere-
bella were isolated and coronal sections were immunostained with the GFP antibody.
Mean migrated distance (A) and distribution (B) of GFP-positive CGNs were assessed.
4404 neurons were analyzed (Kruskal-Wallis, ***p<0.001, mean + s.e.m.) e statistical
test was performed by Dr. S. Papiol. (C) Representative images of (A) and (B). Arrows
indicate transfected CGNs. Scale bar: 50 µm. Dr. J. Stegmüller performed the in vivo
electroporation and Dr. M. Vadhvani took the confocal images.
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3.3. Molecular mechanism of FBXO41-mediated axon
growth and neuronal migration
Following the functional analyses, I proceeded with the dissection of the molecular
mechanism, by which FBXO41 regulates neuronal migration and axon growth. Here
I carried out a candidate approach to identify interactors of FBXO41 that cooperate in
this process.
3.3.1. FBXO41 does not form a canonical Cullin1-based SCF E3
ubiquitin ligase
Most of F-box proteins serve as interchangeable substrate-recognition subunits of
the Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligases (Feldman et al., 1997, Skowyra et al.,
1997). An interaction with both Skp1 and Cullin1 is required for F-box proteins to
form a functional SCF complex (Zheng et al., 2002). To determine if FBXO41 forms a
Cullin1-based SCF complex, we examined the interaction with Cullin1 and Skp1. Using
heterologous cells, we found that FBXO41 associated with Skp1 and that this interaction
depended on the F-box domain (Fig. 3.27 A).
Next, I investigated the FBXO41 and Cullin1 interaction. Again, using a heterolo-
gous cell system, I discovered that while the control F-box protein FBXO31 interacted
with Cullin1, FBXO41 failed to associate with Cullin1 (Fig. 3.27 B). us, these experi-
ments suggest that FBXO41 does not associate with Cullin1 to form a conventional SCF
complex.
To date, among 8 known Cullins, only Cullin1 and Cullin7 (that binds to FBXW8)
have been shown to form SCF complexes (Sarikas et al., 2008). Hence, we went on to
investigate the interaction of FBXO41 and Cullin7 and demonstrated that both proteins
interact inHEK 293T cells (C.Mukherjee, unpublished data). is indicates that FBXO41
is the second identified F-box protein forming a Cullin7-based E3 ubiquitin ligase.
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Figure 3.27.: FBXO41 interacts with Skp1 but not with Cullin1. (A) HEK 293T cells
were transfected with the control plasmid, GFP-FBXO41 or GFP-FBXO41 ∆F-box to-
gether with myc-Skp1 and subjected to immunoprecipitation with the myc antibody.
Lysates were subsequently probed with the GFP antibody. e experiment was per-
formed by Dr. M. Kannan. (B) Lysates from HEK 293T cells transfected with myc-
FBXO41, myc-FBXO31 or empty control vector were immunoprecipitated with the myc
antibody and immunobloed with the Cullin1 antibody.
3.3.2. FBXO41 is a novel interacting partner of DISC1
To identify binding partners that act together with FBXO41 in the control axon
growth and neuronal migration, we took a candidate approach and screened centro-
somal proteins with a role in neural development. Among those, we found DISC1
to associate with FBXO41. Several genetic studies showed association of DISC1 with
schizophrenia and other psychiatric disorders (Millar et al., 2000b, Ekelund et al., 2001,
Hennah et al., 2003). In addition to that, DISC1 has been implicated in cell fate deter-
mination, regulation of neurite outgrowth and neuronal migration (Kamiya et al., 2006,
2005, Mao et al., 2009).
I established a robust interaction of FBXO41 and DISC1, using HEK 293T cells. Here,
I transfected cells with Flag-DISC1 and GFP empty vector or GFP-FBXO41 and used the
lysates to perform an immunoprecipitation with the GFP antibody, demonstrating that
DISC1 indeed binds to FBXO41 (Fig. 3.28 A). Further, I confirmed this result by con-
ducting a reciprocal co-immunoprecipitation, where I immunoprecipitated Flag-DISC1
and detected bound myc-FBXO41 (Fig. 3.28 B). To corroborate the finding that FBXO41
forms a complex with DISC1, I examined the localization of GFP-FBXO41 and Flag-
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DISC1 in HEK 293T and observed that both proteins colocalize at the centrosome and
in the cytoplasm (Fig. 3.28 C). ese results demonstrate that FBXO41 is an interactor
of DISC1.
Figure 3.28.: FBXO41 interacts with DISC1. (A, B) HEK293T cells were transfected
with the indicated plasmids and lysed 3 days later. 10% of the lysates were used as
an input control. e remaining lysates were subjected to immunoprecipitation with
the GFP (A) or Flag (B) antibodies and subsequently immunobloed with the indicated
antibodies. (C) HEK 293T cells were transfectedwith the GFP-FBXO41 plasmid together
with the Flag-DISC1. Cells were subjected to immunocytochemistry using the Flag and
GFP antibodies and the DNA dye bisbenzimide Hoechst 33258. Scale bar: 10 µm.
3.3.3. DISC1 mediates the interaction between FBXO41 and
NDEL1
Strikingly, I also found that another centrosomal protein, implicated in migration,
associates with FBXO41 via DISC1. I examined if FBXO41 forms a complex with DISC1
and NDEL1 in HEK 293T cells and observed that FBXO41 can be immunoprecipitated
with NDEL1 in the presence of DISC1. (Fig. 3.29). is finding establishes DISC1 as a
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link between FBXO41 and NDEL1.
Figure 3.29.: FBXO41 interacts with NDEL1 in the presence of DISC1. HEK 293T cells
were transfected with indicated plasmids and lysed 2 days later. e lysates were subse-
quently immunoprecipitated with the Flag antibody and immunobloed with the myc
and GFP antibodies.
3.3.4. DISC1 is not a proteolytic target of FBXO41-Cullin7 SCF
complex
Since FBXO41 forms a Cullin7-based SCF complex, the question arose if FBXO41 ubiq-
uitinates DISC1, and possibly targets it for proteasomal degradation. I first tested if
DISC1 accumulates in the FBXO41−/− brain and I subjected lysates from P16 cerebella
and cortices to immunobloing with the DISC1 antibody but did not observe a differ-
ence in the protein expression level of wild type as compared to FBXO41 knockout (Fig.
3.30 A, C). Immunobloing with the antibody that was preincubated with the blocking
peptide, verified the specific detection of DISC1 (Fig. 3.30 B). is experiment suggests
that DISC1 is not targeted for proteasomal degradation by FBXO41.
Apart from proteasomal degradation, ubiquitination can lead to functional modifica-
tions (Chau et al., 1989, Galan and Haguenauer-Tsapis, 1997, Chen et al., 1996). In that
case, levels of the targeted protein may not change. For this reason, I investigated if
DISC1 can be a target of the FBXO41-SCF complex, by performing a CoIP of Cullin7
and DISC1 in the presence or absence of FBXO41. e experiment demonstrated lack
77
3. Results
Figure 3.30.: DISC1 does not accumulate in the FBXO41−/− mice. (A, B, C, D) Lysates
from cortex and cerebellum of indicated ages were immunobloed with the DISC1 an-
tibody (A, C, D) or with the DISC1 antibody that was preincubated with a blocking
peptide (B). γ-Tubulin antibody was used as a loading control.
of physical association of DISC1 and Cullin7-FBXO41 complex, suggesting that DISC1
is not a target of the E3 ligase (Fig 3.31).
Figure 3.31.: Cullin7 does not associate with DISC1. Lysates from HEK 293T cells
transfected with indicated plasmids were immunoprecipitated with the myc antibody
and probed with the Flag and FBXO41 antibodies.
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3.3.5. NDEL1 accumulates upon FBXO41 knockout
To investigate if FBXO41 mediates ubiquitination and degradation of NDEL1, I an-
alyzed NDEL1 expression in the FBXO41+/+, FBXO41+/− and FBXO41−/− mice. Im-
munobloing with the NDEL1 antibody did not show any change across genotypes at
P16 but an accumulation of NDEL1 was observed in at P5 FBXO41+/− and FBXO41−/−
cerebella (Fig. 3.32). is result suggests that the FBXO41 affects the levels of NDEL1
in mouse cerebellum at an age, which is crucial for neuronal migration.
Figure 3.32.: FBXO41 affects expression levels of NDEL1 in P5 cerebellum. Lysates
of P5 and P16 cerebella of FBXO41+/+, FBXO41+/− and FBXO41−/− mice were im-
munobloed with the NDEL1 and the γ-Tubulin antibodies. e laer served as a load-
ing control.
3.3.6. The CTR domain of FBXO41 mediates the interaction with
DISC1
To determine if FBXO41 controls axon growth and neuronal migration in a DISC1-de-
pendent manner, we used GFP-tagged FBXO41 truncation constructs and myc-DISC1
to transfect HEK293T prior to immunoprecipitation with the GFP antibody. Subse-
quent immunobloing with the myc antibody showed that only the deletion mutants
of FBXO41 that lack the C-terminal fragment of the CTR did not interact with DISC1,
identifying this stretch as DISC1-binding region (Fig. 3.33).
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Figure 3.33.: DISC1 binds to the CTR of FBXO41. (A) Schematic of various deletion
mutants of FBXO41 and their interaction with DISC1. (B) HEK293T cells transfected
with the GFP-tagged deletion mutants of FBXO41 together with the myc-DISC1 were
lysed 3 days later and subjected to immunoprecipitation with the GFP antibody and
detection with the myc antibody. is experiment was performed by Dr. J. Stegmüller
and Dr. M. Kannan.
3.3.7. FBXO41 and DISC1 act in parallel pathways to control
axon growth
Having established the CTR as binding region of DISC1, this also led to the conclusion
that FBXO41 ∆CTR-stimulated axon growth is DISC1-independent (see sections 3.2.4
and 3.2.5 for the details).
To gain further insight into the FBXO41-DISC1 interaction in axon growth, I per-
formed epistasis analysis by overexpressing FBXO41 and downregulating DISC1 in
CGNs. For this purpose D. Brockelt generated a DISC1 RNAi and I verified the efficiency
of the knockdown by transfecting HEK 293T cells with myc-DISC1 construct together
with either the U6 empty vector or the RNAi vector. Subsequently, I immunoblot-
ted the lysates with the myc antibody and observed a reduction in DISC1 level upon
overexpressing the RNAi (Fig. 3.34 A). Analysis of CGNs, transfected with the control
plasmids, the FBXO41 plasmid, the DISC1 RNAi plasmid or with the FBXO41 together
with the DISC1 RNAi plasmids, revealed that while FBXO41 overexpression increased
axon length, DISC1 knockdown resulted in a decrease. e axon length of neurons
expressing both plasmids was similar to control neurons. ese findings suggest that
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FBXO41 and DISC1 regulate axon growth independent from each other (Fig. 3.34 B, C).
Figure 3.34.: DISC1 and FBXO41 act in separate pathways to control axon growth. (A)
HEK 293T cells were transfected with the control vector and the DISC1 RNAi together
with myc-DISC1. Lysates obtained aer 4 days were probed with the myc antibody.
Pan 14-3-3 served as a loading control. (B) CGNs were transfected with empty control
vectors, DISC1 RNAi, myc-FBXO41, or both plasmids together and axon length was
measured aer 4 days. A total of 763 neurons was analyzed. (ANOVA, ***p<0.001,
mean + s.e.m.). (C) Representative images of (B). Arrows indicate axons. Scale bar: 100
µm.
3.3.8. DISC1-binding is essential for FBXO41-mediated control
of neuronal migration
As I demonstrated before (see section 3.2.6), the migration-promoting effect of
FBXO41 requires the presence of the CTR, indicating that the interaction with DISC1
is also important for this process. In order to corroborate this finding, I generated and
validated a bicistronic DISC1 RNAi plasmid that co-expressed EGFP to visualize trans-
fected neurons (Fig. 3.35).
Next, we electroporated P4 rat pups with the control plasmid, FBXO41 RNAi, DISC1
81
3. Results
Figure 3.35.: Bicistronic RNAi downregulates DISC1 protein level. (A) HEK 293T cells
transfected with the indicated plasmids were lysed 4 days later and subjected to im-
munobloing with the myc and pan 14-3-3 antibodies. e laer served as a loading
control.
RNAi or FBXO41 RNAi and DISC1 RNAi together. Aer 5 days, the measurement of
distance the CGNs migrated showed that while, FBXO41 RNAi and DISC1 RNAi signif-
icantly inhibited migration, simultaneous knockdown of FBXO41 and DISC1 decreased
migration even further (Fig. 3.36). is result suggests that FBXO41 and DISC1 func-
tionally interact to regulate neuronal migration.
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Figure 3.36.: FBXO41 and DISC1 cooperate to regulate neuronal migration. (A,
B) Rat pups were electroporated at postnatal day 4 with U6-CMV-EGFP (Control),
U6-FBXO41RNAi-CMV-EGFP (FBXO41 RNAi) or U6-DISC1RNAi-CMV-EGFP (DISC1
RNAi) plasmids. 5 days following the electroporation, cerebella were isolated, cut coro-
nally and stained with the GFP antibody to visualize transfected neurons. Mean mi-
grated distance (A) or distribution within the cerebellar cortex (B) were determined for
a total of 4282 neurons (ANOVA, ***p<0.001, mean + s.e.m). (C) Representative images
of (A) and (B). Arrows indicate transfected neurons. Scale bar: 50 µm. e in vivo




During brain development, newborn neurons and neuronal precursors migrate con-
siderable distances and undergo complex morphological changes to generate functional
neuronal circuits. e importance of these processes is substantiated by the fact that
defects in neuronal migration or axon growth result in serious neurodevelopmental
disorders (Gleeson, 2001, Kato and Dobyns, 2003, Lewis and Levi, 2002, Oprea et al.,
2008). us, it is not surprising that the regulation of brain development is governed by
external cues and cell autonomous pathways. While extrinsic mechanisms in the con-
trol of neurodevelopment have been widely described, intrinsic programs, including
the ubiquitin-proteasome system, are beginning to shed further light onto regulation
of developmental events in neurons.
Although the UPS represents a universal cellular machinery, more than 600 different
E3 ubiquitin ligases encoded by the human genome allow for a temporally and spatially
controlled regulation of specific events in the brain (Scheffner et al., 1995). Owing to a
large number of F-box proteins, SCF complex ligases are extremely versatile (Deshaies,
1999) and have aracted a lot of aention in the cell cycle and cancer field (Skaar et al.,
2009, Frescas and Pagano, 2008, Welcker and Clurman, 2008). Only recently, studies
have examined various F-box proteins in the nervous system and revealed significant
roles in brain development and in disease (Westbrook et al., 2008,Wu et al., 2013, Jandke
et al., 2011, Fonzo et al., 2009, Watanabe et al., 2013, Lierman et al., 2011). Hence,
F-box proteins could represent therapeutic targets for disease treatment, as different
approaches have been developed in the past few years (Wu et al., 2012b, Orlicky et al.,
2010, Aghajan et al., 2010, Sakamoto et al., 2001).
FBXO41 is a previously uncharacterized F-box protein, whose mRNA is highly ex-
85
4. Discussion
pressed in several regions of the brain. is study revealed the neuron-specific expres-
sion of FBXO41 in the CNS and its localization at the centrosome and in the cytoplasm.
Moreover, FBXO41 is crucial to cerebellar development as it regulates neuronal migra-
tion and axon growth. Further analysis established the FBXO41/DISC1/NDEL1 inter-
action, which is important for FBXO41-mediated neuronal migration.
4.1. FBXO41 is localized to the centrosome and the
cytoplasm of CNS neurons
FBXO41 has been identified as a brain specific F-box protein by the Cerebellar Devel-
opment Transcriptome Database (CDT-DB). Reverse trancriptase PCR (RT-PCR) carried
out in the lab, confirmed the presence of FBXO41 in CNS regions and its absence from
non-neural tissue.
Since the available data on FBXO41 was restricted to its mRNA levels, we generated
a polyclonal antibody to study the protein expression. e expression profile, which
included neural and non-neural tissues, was consistent with the transcript data. e
temporal expression paern in the mouse cerebellum, obtained from the CDT-DB, in-
dicated a peak in the FBXO41 transcript level at postnatal day 14. As I observed a
similar increase of the protein level in the cerebellum, one can assume that FBXO41 ex-
pression is mainly transcriptionally regulated. Moreover, the upregulation of FBXO41
expression in the mouse embryo suggested a role in neural development. Additionally
its continuous expression until the adulthood suggests, that FBXO41 may have further
functions in synapse formation or maintenance of neuronal networks.
Among different cell types populating the brain, FBXO41 expression is only detectable
in neurons, but not in oligodendrocytes or in astrocytes. Consistent with this finding,
during cerebellar development, the FBXO41 transcript is found in the external granule
layer at P7 and in the internal granule layer at P21. is expression paern corresponds
to the position of cerebellar granule neurons at the above mentioned developmental
stages, underscoring the neuron-specific FBXO41 expression.
To characterize the expression of FBXO41 in more detail, we analyzed its subcellu-
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lar localization in neurons. erefore, we used immunostaining of CGNs expressing a
fluorescently-tagged FBXO41 and observed that it was localized in the axonal and den-
dritic compartment, and at the centrosome. We confirmed this result by centrosomal
purification, which demonstrated that FBXO41 was present both in the cytoplasmic and
in the centrosomal fraction. Since many centrosomal proteins, such as DISC1, NDEL1,
LIS1, DCX have been implicated in neuronal migration (Morris et al., 2003, Kamiya
et al., 2005, Sasaki et al., 2000, Feng et al., 2000, Tanaka et al., 2004), the centrosomal
localization of FBXO41 indicated its possible role in this process.
4.2. FBXO41 promotes neuronal migration in the
cerebellar cortex
Neuronal migration is essential for the establishment of proper wiring and connec-
tivity of the brain and needs to be tightly controlled. Although several proteins in-
volved in governing this process have been described, the exact molecular pathways
remain elusive. Identification of new regulatory proteins could help decipher mecha-
nisms underlying neuronal migration. In recent years several F-box proteins, such as
FBXO31, FBXO45 and FBXW7 have been shown to be implicated in neuronal migration
(Vadhvani et al., 2013, Saiga et al., 2009, Jandke et al., 2011). Due to the centrosomal lo-
calization of FBXO41, we decided to investigate its role in neuronal migration. Using
in vivo electroporation of rat cerebella, we demonstrated, that knockdown of FBXO41
dramatically stalled migrating CGNs. Conversely, migration of CGNs was enhanced by
overexpression of FBXO41.
Given the importance of the centrosome for neuronal migration, we examined if the
centrosomal localization of FBXO41 is essential to regulate migration. We utilized the
the in vivo electroporation system to overexpress FBXO41 ∆CTR in CGN progenitors
and monitor their migration. e non-centrosomal FBXO41 was not able to promote
neuronal migration to the extend of the wild type protein. is finding places FBXO41
among the regulators of neuronal migration, whose function is centrosome-dependent.
For instance, disruption of the centrosomal localization of katanin p60 and its aberrant
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nuclear distribution coincides with defects in migration (Toyo-Oka et al., 2005). Fur-
thermore, overexpression of the polarity protein PAR6α, causes redistribution of cen-
trosomal components, like γ-Tubulin, pericentrin, centrin2, PKCζ and PAR6α, as well
as disrupted neuronal migration (Solecki et al., 2004). Similarly, the loss of centrosomal
localization of FBXO41 interferes with its ability to promote neuronal migration.
However, it is noteworthy that, even though not localized at the centrosome, the
FBXO41 ∆CTR was still able to enhance neuronal migration to a limited extend. It
suggest additional, acentrosomal mechanisms of FBXO41-mediated migration. is is
consistent with the observation of Umeshima and colleagues that during radial migra-
tion of CGNs in organotypic cerebellar slices, the centrosome does not always precede
the nucleus and that the nuclear forward movement can occur without the centrosome
entering the leading process first (Umeshima et al., 2007). e suggested mechanism
of the nuclear movement along the microtubules, into the leading process, involves the
molecular motor activity of the LIS1/dynein complex, localized at the nuclear envelope
(Tanaka et al., 2004, Tsai and Gleeson, 2005). Non-muscle myosin II acts behind the
nucleus, to push it forward (Bellion et al., 2005, Zhu et al., 2010). Moreover, non-muscle
myosin II has also been reported to localize in front of the nucleus, presumably pulling
it towards the migratory direction (Solecki et al., 2009). It remains to be determined, if
the acentrosomal FBXO41 regulate neuronal migration by any of this mechanisms.
During this study, we performed a candidate approach to identify interactors of
FBXO41 and its potential ubiquitination targets, that would cooperate with FBXO41
in regulation of neuronal migration. We screened for proteins that exhibit centroso-
mal and cytoplasmic localization and are expressed from the embryonic development
to adulthood. Furthermore, the candidates were required to have a function in neu-
ronal migration and morphogenesis. As a consequence, we identified DISC1 as a bind-
ing partner of FBXO41. We determined the interaction of FBXO41 and DISC1 by the
co-immunoprecipitation method, and we observed the colocalization of FBXO41 and
DISC1 in HEK 293T cells. is finding is consistent with the results of a yest two-hybrid
screen, that found FBXO41 as one of the candidate interactors of DISC1. However, that
study did not provide any independent evidence for this association (Camargo et al.,
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2007).
e fact that the DISC1 locus has been linked to schizophrenia and related mental
disorders (Ekelund et al., 2001, 2004, Hamshere et al., 2005, Hwu et al., 2003, Macgregor
et al., 2004) prompted many groups to generate DISC1 mouse models. It is however
impossible to study the full spectrum of schizophrenia symptoms in mice. For exam-
ple, some positive symptoms, like delusions and hallucinations cannot be modeled in
animals. Nevertheless, it is still possible to analyze several negative and cognitive hall-
marks in mouse models (Arguello and Gogos, 2006). So far it is not clear what is the
consequence of the balanced translocation in the Scoish family for the expression of
DISC1: it may result in haploinsufficiency or the C-terminally truncated protein could
be expressed and constitute a dominant negative variant of DISC1. Several mouse mod-
els expressing truncated versions of DISC1 have been generated until now. Behavioral
deficits, corresponding to those observed in schizophrenia patients, have been reported
in these mice. Some of them include prolonged immobility in the forced swim test,
hyperactivity, decreased prepulse inhibition. Additionally, males exhibited decreased
social interactions and females showed deficits in working memory (Hikida et al., 2007,
Pletnikov et al., 2008). Some of the animal models display missense mutations within
DISC1 sequence, such as L100P and Q31L substitutions. Mice with the L100P mutation
exhibit more schizophrenia-like phenotype, including deficiency in prepulse inhibition
and latent inhibition, which were reversible upon treatment with antipsychotics. Mice
with the Q31L mutation in turn, exhibit more depression-like behavior, with not so pro-
nounced deficit in prepulse inhibition, but with shortcoming in latent inhibition and
the forced swim test(Clapcote et al., 2007). Interestingly, FBXO41 locus has been found
within one of the genomic regions, that have been linked to schizophrenia (Nato et al.,
2006). Moreover, a functional gene group analysis demonstrated that a group of synap-
tic genes containing FBXO41 was associated with the risk of schizophrenia (Lips et al.,
2012). In this context, it would be interesting to perform the schizophrenia-relevant be-
havioral tests such as prepulse inhibition to analyze the sensory gating, 5-choice serial
reaction time task and latent inhibition to test aentional deficits, delayed nonmatch to
position or T maze test to determine the working memory deficits, forced swim test to
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examine depression as well as novel object recognition task, which can be used to deter-
mine functions related to hippocampus and cortex, especially visual working memory
(Arguello and Gogos, 2006, Niwa et al., 2010) on the FBXO41-deficient mice. Since the
FBXO41 knockout mice exhibit a severe motor phenotype, using the heterozygous an-
imals would probably ensure more reliable results.
DISC1 has been shown to promote migration of neurons in the developing brain, but
appears to restrict the speed of neuronal integration in the adult hippocampus (Duan
et al., 2007). Aside from neuronal migration in the cortex, DISC1 controls migration
of granule and pyramidal neurons in the hippocampus (Kamiya et al., 2005, Meyer and
Morris, 2009, Tomita et al., 2011). Consistently with these data, I found that knockdown
of DISC1 inhibits migration of cerebellar granule neurons, which is similar to the effect
of FBXO41 knockdown. I also discovered that the double knockdown of FBXO41 and
DISC1 led to amore pronounced phenotype. A study fromDuan and colleagues demon-
strated that another binding partner of DISC1 - NDEL1, also showed an additive effect
ofmigration inhibition, when downregulated together with DISC1. is finding implied
that NDEL1 and DISC1 functionally interact to regulate migration (Duan et al., 2007).
Along that line my data suggests that FBXO41may control neuronal migration together
with DISC1. Further in vivo electroporation experiment overexpressing FBXO41WT or
the ∆CTR mutant, that does not bind to DISC1 supported this conclusion. is result
demonstrated that the interaction with DISC1 is crucial for FBXO41 to properly support
neuronal migration. e finding that FBXO41 has residual activity to promote neuronal
migration without interacting with DISC1 could imply that FBXO41 controls neuronal
positioning by an additional parallel pathway that may involve microtubule binding
proteins (Bielas et al., 2004).
DISC1 regulates neuronal migration by interacting with a variety of proteins, includ-
ing BBS4 (Kamiya et al., 2005), CAMD1 (Fukuda et al., 2010), kinesin-1 (Kamiya et al.,
2005) and probably the best characterized NDEL1-LIS1-dynein complex (Duan et al.,
2007, Torisawa et al., 2011). In the present study, I demonstrated an interaction of
FBXO41 with NDEL1, that occurs in the presence of DISC1. Phosphorylation of both,
DISC1 and NDEL1 is necessary for their function in neuronal migration. DISC1 be-
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comes phosphorylated at serine 710 to switch from a regulator of proliferation tomigra-
tion (Ishizuka et al., 2011b). e phosphorylation of NDEL1 by Cdk5 (cyclin-dependent
kinase 5) promotes NDEL1’s interactionwith katanin p60. is ensures the proper local-
ization of NDEL1, which is necessary for neuronal migration (Toyo-Oka et al., 2005). By
associating with DISC1 and NDEL1, FBXO41 might affect their phosphorylation state
in the control of neuronal migration. Examining the levels of phosphorylated DISC1
or NDEL1 in the FBXO41 knockout mice, using the phospho-specific antibodies would
shed more light on that subject.
NDEL1 interacts with LIS1 to regulate cytoplasmic dynein during migration (Tori-
sawa et al., 2011). It would therefore be of great relevance to examine if FBXO41 acts
on dynein activity. An established method to analyze dynein function is to monitor
the transport of its cargo in living cells. is approach would also be useful to assess
dynein activity in the neurons devoid of FBXO41.
Apart from regulating the transport of cellular cargo during migration, the NDEL1-
LIS1-dynein complex has been also implicated in nuclear translocation and centrosome-
nucleus coupling (Shu et al., 2004). Hence, analysis of the nuclear movement and the
distance between nucleus and the centrosome in FBXO41-depleted neurons would pro-
vide a deeper insight into the mechanisms underlying FBXO41 function in neuronal
migration.
FBXO41 may also regulate neuronal migration by modulating the actin cytoskeleton.
It has been reported that NDEL1 is necessary for activating the RhoGTPase Cdc42 at the
leading edge of migrating neurons (Shen et al., 2008). Activity levels of Cdc42 FBXO41
knockout neurons might thus provide an indication whether FBXO41 is involved in
NDEL1-mediated regulation of Cdc42.
NDEL1 and its interacting partners have been implicated in several other molecu-
lar pathways that control neuronal migration. For instance, migration defects and in-
creased distance between the centrosome and the nucleus observed in the LIS1+/− neu-
rons can be rescued by overexpression of DCX (Doublecortin). is suggests a func-
tional cooperation of both proteins (Tanaka et al., 2004). In migrating neurons, the
PAR6α/PKCζ activity is localized at the centrosome and controls its movement in the
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direction of migration. Overexpression of PAR6α disrupts the centrosomal localization
of proteins like γ-Tubulin, pericentrin, centrin2, PKCζ as well as PAR6α itself and in-
hibits neuronal migration (Solecki et al., 2004). Additional investigation would be nec-
essary to determine if some of the aforementioned regulators cooperate with FBXO41
to form a regulatory pathways governing neuronal migration.
4.3. FBXO41 forms a Cullin7-based E3 ubiquitin
ligase
In order to identify mechanisms by which FBXO41 regulates neuronal migration, I
addressed if FBXO41, similar to other F-box proteins, is part of an SCF E3 ligase and
ubiquitinates proteins involved in the regulation of neuronal motility. Co-immunopre-
cipitation experiments performed in this study demonstrated, that FBXO41 interacts
with Skp1 and this interaction is F-box domain-dependent. However, unlike most F-box
proteins, FBXO41 does not associate with Cullin1 to form an SCF complex. Analysis of
the crystal structure of SCFSkp2 complex revealed that Skp2 interacts with Cullin1 not
only via Skp1, but also directly through two amino acids within the F-box domain (P113
and E115 in case of Skp2) (Zheng et al., 2002). As it has been demonstrated for the F-box
protein FBXO45, reconstitution of only one of these crucial amino acids can restore the
interaction with Cullin1 (Saiga et al., 2009). Alignment of several Cullin1-binding F-box
proteins and FBXO41 revealed that the crucial proline and glutamic acid are replaced by
arginine and alanine in FBXO41. is results in a distinct interface for Cullin1 binding
to FBXO41, which is consistent with the negative CoIP results.
Few other F-box proteins have been demonstrated to act independently of the SCF
complex to regulate cellular processes. Mdm30 and M1 control mitochondria mor-
phology, Ctf13 is a centromere-binding protein (which also interacts with Skp1) and
Fbh1 exhibits helicase activity (Dürr et al., 2006, Kitagawa et al., 1999, Kim et al., 2002,
2004). Aside from Cullin1, Cullin7 has also been reported to build the foundation of an
SCF complex (Jin et al., 2004). FBXW8 is the only protein known so far to form Cullin7-
based SCF complex, but such a complex differs in several aspects from the canonical
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SCF ligase. For example, FBXW8 does not bind to Cullin7 via its F-box domain but
utilizes the WD40 domain instead. Moreover, while Cullin 1 binds directly to Skp1,
no interaction between Cullin7 and Skp1 can be detected when FBXW8 is not present.
us, Skp1 is recruited to Cullin7 by FBXW8 and binds to its F-box domain (Dias et al.,
2002). Also the mechanism of substrate binding to the Cullin7-FBXW8 complex is not
clear. However it has been recently suggested that Cul7/Rbx1/FBXW8 may associate
with Cul1/Rbx1/F-box to facilitate the ubiquitination of its substrates (Ponyeam and
Hagen, 2012). e interaction may occur between FBXW8 and various F-box proteins
of the SCF complex (Ponyeam and Hagen, 2012). Hitherto, only a limited number of
substrates have been identified for the Cullin7-based ubiquitin ligase. ese include
cyclin D1, IRS-1 (insulin receptor substrate 1) and a Golgi protein, GRASP65 (Xu et al.,
2008, Okabe et al., 2006, Lierman et al., 2011). Experiments performed by C. Mukher-
jee demonstrated that FBXO41 constitutes a second known F-box protein interacting
with Cullin7.
Having identified a novel Cullin7-based E3 ligase, I was prompted to examine DISC1
and NDEL1 as potential substrates. In case of DISC1, there was neither a change of
expression level in the FBXO41 knockout brain, nor did DISC1 interact with Cullin7,
indicating that it is not a substrate of FBXO41. However, NDEL1 accumulated in the
FBXO41 knockout cerebellum at P5 when the neuronal migration takes place but not at
P16, when the migration is completed. is result suggests that FBXO41 affects the lev-
els of NDEL1 in migrating neurons and is consistent with the fact that overexpression
of NDEL1 has been found to impair neuronal migration (Shmueli et al., 2010). Hence,
elevated levels of NDEL1 resulting from the FBXO41 downregulation may underlie the
migration defects observed upon the knockdown of FBXO41 in rat cerebella and in the
FBXO41 knockout mice. Further experiments, including in vitro and in vivo ubiquitina-
tion studies would be necessary to determine if FBXO41 regulates the NDEL1 levels in
a ligase activity-dependent manner.
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4.4. FBXO41 is a selective regulator of axon growth
Since FBXO41 knockout brains did not show any signs of apoptosis, I decided to
examine other aspects of neurodevelopment. Strikingly, FBXO41 appears to exclusively
stimulate axon but not dendrite growth. Since microtubule polymerization is crucial for
axon growth (Tanaka et al., 1995) and the centrosome constitutes the main microtubule
nucleation site (Baas et al., 2005b), I investigated if the axon growth-promoting effect of
FBXO41 depends on its centrosomal localization. I demonstrated that even though not
localized at the centrosome, the FBXO41 ∆CTR stimulated axon growth as potently as
FBXO41 WT, suggesting that the centrosomal localization is dispensable for FBXO41-
mediated axon growth regulation.
Although the centrosome has been shown to play an important role in axon specifica-
tion in vitro (Zmuda and Rivas, 1998), a recent study demonstrated that centrosome abla-
tion in isolated rodent hippocampal neurons did not disturb axon extension. Addition-
ally, acentrosomal microtubule nucleation was observed in the ablated neurons (Stiess
et al., 2010). Consistent with this finding, FBXO41 may utilize centrosome-independent
mechanisms of cytoskeletal regulation in the control of axon growth.
A variety a regulatory pathways is involved in the control of axon growth. DISC1
is one of the important neurite growth-promoting proteins (Kamiya et al., 2005). Since
FBXO41 interacts with DISC1, I analyzed if FBXO41 cooperates with DISC1 to induce
axon growth. e overexpression experiments demonstrated that the mutant of
FBXO41 that does not bind DISC1, still promotes axon growth to the extend of the
wild type FBXO41. us, DISC1 binding to FBXO41 is dispensable for axon growth
regulation. is finding was substantiated by the epistasis analysis, which showed,
that the opposite effects of FBXO41 overexpression and DISC1 knockdown neutralize
each others phenotype in CGNs. e epistasis experiment demonstrated that DISC1
and FBXO41 act independently to regulate axonal length. Control of axon growth in-
cludes for instance the kinase GSK3 with its targets APC, CLASP2, CRMP-2, MAP1B
and tau (Zhou and Snider, 2006). Moreover, JNK (c-Jun N-terminal kinase) and MAP
kinase pathway have been suggested to play a role in axon elongation (Xiao et al., 2006,
Ciani and Salinas, 2007, Markus et al., 2002b). It remains to be elucidated if FBXO41
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participates in one of the aforementioned pathways to promote axon growth.
Analyses of dendrite length and complexity revealed that FBXO41 is a selective regu-
lator of axon but not dendrite growth. Many proteins that control neural development,
like DISC1 (Kamiya et al., 2005) or FBXO31 (Vadhvani et al., 2013) are involved in gen-
eral mechanisms of neurite extension. However, it is also essential that either axon
growth or dendrite growth can be controlled independently from each other. Several
factors, such as p300–SnoN complex (Ikeuchi et al., 2009) or NeuroD (Gaudillière et al.,
2004) act solely on axon or dendrite growth, respectively. Although FBXO41 is localized
both in the axon and in dendrites, it restricts its growth-controlling function only to the
axon. Since it is not the compartmentalization that grants the spatial selectivity in the
case of FBXO41, other mechanisms have to apply. One of the possible explanations is
an interaction with an axon-specific protein, that would mediate the growth-promoting
effect of FBXO41. is is consistent with the finding of my colleague, C. Mukherjee,
who identified NFM (neurofilament medium polypeptide) as an interacting partner of
FBXO41. NFM has been implicated in regulation of axon diameter and thus control-
ling its conduction properties (Friede and Samorajski, 1970, Sakaguchi et al., 1993), but
no clear line of evidence on NFM in axon elongation has been published so far. C.
Mukherjee demonstrated that NFM knockdown in rat CGNs increases axon length and
that FBXO41 and NFM regulate axon growth in a cooperative manner. It remains to be
determined if NFM is ubiquitinated by SCFFBXO41 or if FBXO41 exerts its axon growth
regulation by employing a ubiquitination-independent mechanisms.
Given the cytoplasmic localization of FBXO41 in neurons, it is possible that it con-
trols not only axon growth, but also other cellular processes like neurogenesis, dendritic
spine maturation and synaptic function. Interestingly, DISC1 is also involved in the
control of neural progenitor proliferation and synaptic transmission. DISC1 promotes
neurogenesis by interactingwith GSK3β. is interaction deactivates GSK3β, which re-
duces the phosphorylation of β-catenin and stabilizes it (Mao et al., 2009). Furthermore,
DISC1 regulates the spine size of the glutamatergic synapses by regulating the activity
of Rac1 (Hayashi-Takagi et al., 2010). It requires further investigation if FBXO41 plays
a role in neural progenitor proliferation and synaptic function, as well as determining
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if interaction with DISC1 may be important for the regulation of these processes.
4.5. Perspective: FBXO41 in disease and regeneration
Disruption of neuronal migration and morphogenesis oen leads to neurodevelop-
mental and neurodegenerative disorders. One group of the neurodevelopmental disor-
ders, congenital ataxias, results mainly from the defects in neural development and is
characterized by various malformations of the cerebellar structure as well as of other
brain regions and CNS-independent defects. Patients suffering from ataxia display mo-
tor dysfunction, muscle hypotonia and impairment of development (Millen and Glee-
son, 2008). Anatomical analysis provide a basis for distinguishing different types of
ataxias. For instance Joubert syndrome is characterized by defects of the brainstem,
cerebellum and the cerebellar peduncles (Maria et al., 1999). In turn, hypoplastic vermis,
enlarged fourth ventricle and enlarged posterior skull are the hallmarks of the Dandy-
Walker malformation (Parisi and Dobyns, 2003, Forzano et al., 2007). Given the motor
phenotype of the FBXO41 knockout mice, including abnormal gait, disturbed balance
and tremors, it is possible that mutations in FBXO41 may cause congenital ataxia.
Lissencephaly or “smooth brain” is one of the best characterized disorders caused
by defective migration. It is mainly associated with mutations in two genes, LIS1
(Lissencephaly 1) (Reiner et al., 1993) and DCX (Doublecortin) (Gleeson et al., 1998).
e common symptoms of lissencephaly are: smooth brain surface, cerebral cortex con-
sisting of four aberrant layers, hypoplastic cerebellum, intractable epilepsy, hypotonia
and mental retardation (Dobyns and Truwit, 1995). LIS1 heterozygous mice exhibit ab-
normal layering in the cortex, cerebellum, hippocampus and olfactory bulb (Cahana
et al., 2001). Furthermore, the heterozygous animals show motor defects and impaired
cognition (Paylor et al., 1999). FBXO41 knockout mice share some of these phenotypes,
including developmental defects of cerebellum and motor deficits. erefore, it would
be interesting to examine the lamination of other brain areas of FBXO41 knockout and
heterozygous mice. Behavioral tests could also provide more insight into the cognitive
abilities of the FBXO41-deficient animals. Additionally, several of the genes implicated
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in lissencephaly regulate not only neuronal migration but also axon outgrowth (Kara
et al., 2010). In concomitancewith that, the pathology of lissencephaly shows abnormal-
ities in axon growth and guidance (Grabham et al., 2007, Deuel et al., 2006). Disruption
of axon growth leads to white maer deformations, agenesis of the corpus callosum
and enlarged ventricles in the lissencephaly patients. e resulting failure to establish
proper connectivity in the brain may cause the seizure symptoms (Liu, 2011). Abnor-
mal axonal tracts are also one of the hallmarks of subcortical band heterotopia, which
affects women with mutations in the DCX gene (Gleeson et al., 1999). Hence, while
the axon growth of isolated FBXO41 knockout neurons is significantly impaired, an in
depth analysis of the main axonal tracts in the FBXO41 knockout mousemay provide an
insight on whether or not FBXO41 deficit results in the connectivity disruption, similar
to that observed in the lissencephaly patients.
Also mutations in genes, whose products regulate axon growth and migration have
been associated with several neurodegenerative diseases. For instance mutations in the
PFN1 (profilin 1) gene have been shown to cause familiar amyotrophic lateral sclerosis
(FALS) (Wu et al., 2012a). PFN1 regulates actin polymerization and overexpression of its
ALS-linkedmutants inhibits axon growth (Wu et al., 2012a). Moreover, mutations in the
SMN1 (survival motoneuron 1) gene are associated with spinal muscular atrophy (SMA).
SMN1 deficit in mouse motor neurons causes reduction in axonal, but not dendritic
length and its overexpression in PC12 cells promotes the growth of neurites (Rossoll
et al., 2003). Since both diseases are characterized by motor neuron loss, it would be
important to assess the survival of motoneurons in FBXO41 knockout mice.
e stimulation of axon growth is a major problem in the CNS aer injury. While
peripheral neurons have a substantial regenerative potential, neurons of the CNS fail
to regrow axons. Various gene therapy approaches have been applied to increase the
regenerative abilities of injured neurons. Most of them include local delivery of growth
factors, but it has been shown that simultaneous stimulation of intracellular signaling
improves the outcome of the therapy (Hollis II et al., 2009), making FBXO41 an inter-
esting clinical target. However, while my study demonstrates that FBXO41 promotes
axon growth in the developing neurons, the mechanisms of axon regeneration may
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differ from the ones in the initial axon development (Blizzard et al., 2007). Addition-
ally, the mature CNS constitutes an unfavorable environment for axon regeneration,
which can be aributed to several factors. First of all, myelin proteins like NOGO,
MAG (myelin-associated glycoprotein), and Omgp (oligodendrocyte-myelin glycopro-
tein) (Xie and Zheng, 2008) as well as the lipid sulfatide (Winzeler et al., 2011) are known
inhibitors of axon growth. Furthermore, the growth factor deficit (Tuszynski, M.H.,
Lu, 2008, Widenfalk et al., 2001) and the presence of repulsive guidance cues such as
ephrins, semaphorins and netrins (Benson et al., 2005, Bolsover et al., 2008, Löw et al.,
2008, Niclou et al., 2003) contribute to the inhibition of nerve regeneration. Finally,
axon growth is also restricted by the glial scar (Fitch and Silver, 2008, Silver and Miller,
2004), inflammatory processes (Popovich andMcTigue, 2009) and components of the ex-
tracellular matrix, like chondroitin-sulfateproteoglycans (Silver andMiller, 2004). us,
additional in vitro and in vivo injury studies could shed more light on the regenerative
potential of FBXO41 overexpression. Axon growth assays using myelin coated plates
and evaluation of FBXO41 effect upon optic nerve crush or in spinal cord injury models
could provide more insight into its role in the regeneration processes.
4.6. Conclusion
My study identified the F-box protein FBXO41 as a novel neuron-specific protein in
the CNS. I found that FBXO41 is a crucial regulator of cerebellar development (Fig. 4.1).
FBXO41 acts together with DISC1 at the centrosome to promote neuronal migration of
CGNs in the cerebellar cortex. Also, DISC1 bridges FBXO41’s association with NDEL1,
a known regulator of neuronal migration. Moreover, FBXO41 may affect the expres-
sion levels of NDEL1, which is crucial for correct migration. In addition, I demonstrated
that although the interaction of FBXO41 and DISC1 is required for proper neuronal mi-
gration, this interaction is dispensable for FBXO41’s role in axon growth regulation of
CGNs. Finally, the generation of an FBXO41 knockout mouse enabled to confirm the
neurodevelopmental role of FBXO41 in the cerebellum. Taken together, my study con-
stitutes an important step towards understanding the molecular pathways that regulate
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the development of the cerebellum. It also contributes to a beer understanding of the
functions of F-box proteins in this process. Ultimately, my results may establish a basis
for the identification of new causative genes for neurodevelopmental disorders such as
congenital ataxias and provide a source of potential therapeutic approaches.
Figure 4.1.: FBXO41 is amultifunctional protein in neurons. FBXO41 is localized to the
centrosome and to the cytoplasm, including axons and dendrites. FBXO41’s function
in neurons is tightly connected to its localization and likely determined by its distinct
interacting partners. Centrosomal FBXO41 regulates neuronal migration and the inter-
action with DISC1 is indispensable for this process. Moreover, my study demonstrated
that FBXO41 forms a complex with NDEL1 in the presence of DISC1, and this interac-
tion may be crucial for assuring of proper expression levels of NDEL1. On the other
hand, cytoplasmic FBXO41 acts as a positive regulator of axon growth. Interaction with
axonal proteins like NFMmay mediate the function of FBXO41 in axon growth control.
Additionally, cytoplasmic localization of FBXO41, may indicate its function in dendritic
spine development or synaptic function, which remains to be determined. Dashed lines
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Suvisaari, J., Lönnqvist, J., Meyer, J., and Peltonen, L. (2001). Chromosome 1 loci in
Finnish schizophrenia families. Human molecular genetics, 10(15):1611–7.
Ekelund, J., Lichtermann, D., Hovaa, I., Ellonen, P., Suvisaari, J., Terwilliger, J. D.,
Juvonen, H., Varilo, T., Arajärvi, R., Kokko-Sahin, M.-L., Lönnqvist, J., and Peltonen,
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(2003). Haplotype transmission analysis provides evidence of association for DISC1
to schizophrenia and suggests sex-dependent effects. Human molecular genetics,
12(23):3151–9.
114
Hershko, A., Ciechanover, A., and Rose, I. A. (1981). Identification of the active amino
acid residue of the polypeptide of ATP-dependent protein breakdown. Journal of
Biological Chemistry, 256(4):1525–1528.
Hershko, A., Heller, H., Elias, S., and Ciechanover, A. (1983). Components of ubiquitin-
protein ligase system. Resolution, affinity purification, and role in protein breakdown.
Journal of Biological Chemistry, 258(13):8206–8214.
Hicke, L. (2001). Protein regulation by monoubiquitin . Nat Rev Mol Cell Biol, 2(3):195–
201.
Higginbotham, H. R. and Gleeson, J. G. (2007). e centrosome in neuronal develop-
ment. Trends in Neurosciences, 30(6):276–283.
Hikida, T., Jaaro-Peled, H., Seshadri, S., Oishi, K., Hookway, C., Kong, S., Wu, D.,
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